ICRP 123: negative pion - dawki narządowe i współczynniki jakości
Źródło: ICRP Publication 123, Assessment of Radiation Exposure of Astronauts in Space, supplementary data, Annals of the ICRP 42(4), 2013, strony PDF: arkusz negative pion. Podpis w źródle: Supplementary data workbook P 123 JAICRP 42(4) DB of pion.xls, sheet negative pion
Znormalizowana macierz danych ICRP 123 dla cząstki negative pion: energia, narząd lub wielkość efektywna, płeć fantomu, typ wielkości, jednostka i wartość. Dane obejmują współczynniki konwersji fluencji cząstek na dawkę pochłoniętą oraz średnie współczynniki jakości w geometrii izotropowej.
Źródłowe arkusze miały układ szeroki z wielopoziomowymi nagłówkami; import zapisano w układzie długim, aby można było filtrować po energii, narządzie, płci i typie wielkości.
Kolumny SwTDT/F, DT/F, QICRP60 i QNASA zachowują nazwy źródłowe z arkusza. Jednostka pGy cm2 lub pSv cm2 jest podana w kolumnie jednostka wartości.
Pokazano 7869 z 7869 wierszy.
| Cząstka | Symbol | Z | A | Energia | Jednostka energii | Narząd/tkanka albo wielkość | Płeć/fantom | Wielkość źródłowa | Opis wielkości | Jednostka wartości | Wartość |
|---|---|---|---|---|---|---|---|---|---|---|---|
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 88 | ||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 90.4 | ||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 85.6 | ||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 1 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 1 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.8 | ||
| negative pion | pi- | 1 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 1 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.7 | ||
| negative pion | pi- | 1 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 1 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 214 | ||
| negative pion | pi- | 1 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 1 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181 | ||
| negative pion | pi- | 1 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.8 | ||
| negative pion | pi- | 1 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.7 | ||
| negative pion | pi- | 1 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.4 | ||
| negative pion | pi- | 1 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.9 | ||
| negative pion | pi- | 1 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.1 | ||
| negative pion | pi- | 1 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55 | ||
| negative pion | pi- | 1 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124 | ||
| negative pion | pi- | 1 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35 | ||
| negative pion | pi- | 1 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.1 | ||
| negative pion | pi- | 1 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.3 | ||
| negative pion | pi- | 1 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.2 | ||
| negative pion | pi- | 1 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53 | ||
| negative pion | pi- | 1 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.3 | ||
| negative pion | pi- | 1 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.9 | ||
| negative pion | pi- | 1 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.3 | ||
| negative pion | pi- | 1 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.5 | ||
| negative pion | pi- | 1 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.2 | ||
| negative pion | pi- | 1 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.2 | ||
| negative pion | pi- | 1 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66 | ||
| negative pion | pi- | 1 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.7 | ||
| negative pion | pi- | 1 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106 | ||
| negative pion | pi- | 1 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 1 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.7 | ||
| negative pion | pi- | 1 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 1 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1300 | ||
| negative pion | pi- | 1 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |||
| negative pion | pi- | 1 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |||
| negative pion | pi- | 1 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1470 | ||
| negative pion | pi- | 1 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |||
| negative pion | pi- | 1 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |||
| negative pion | pi- | 1 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.6 | ||
| negative pion | pi- | 1 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.8 | ||
| negative pion | pi- | 1 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.2 | ||
| negative pion | pi- | 1 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 1 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.8 | ||
| negative pion | pi- | 1 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 1 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111 | ||
| negative pion | pi- | 1 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.2 | ||
| negative pion | pi- | 1 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36 | ||
| negative pion | pi- | 1 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.5 | ||
| negative pion | pi- | 1 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.3 | ||
| negative pion | pi- | 1 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.4 | ||
| negative pion | pi- | 1 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.7 | ||
| negative pion | pi- | 1 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.4 | ||
| negative pion | pi- | 1 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65 | ||
| negative pion | pi- | 1 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65 | ||
| negative pion | pi- | 1 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.7 | ||
| negative pion | pi- | 1 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.7 | ||
| negative pion | pi- | 1 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 1 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.6 | ||
| negative pion | pi- | 1 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 1 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.3 | ||
| negative pion | pi- | 1 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 1 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30.6 | ||
| negative pion | pi- | 1 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 1 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.7 | ||
| negative pion | pi- | 1 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.6 | ||
| negative pion | pi- | 1 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34.4 | ||
| negative pion | pi- | 1 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 1 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.8 | ||
| negative pion | pi- | 1 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.1 | ||
| negative pion | pi- | 1 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.9 | ||
| negative pion | pi- | 1 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.8 | ||
| negative pion | pi- | 1 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.4 | ||
| negative pion | pi- | 1 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.7 | ||
| negative pion | pi- | 1 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 286 | ||
| negative pion | pi- | 1 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |||
| negative pion | pi- | 1 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |||
| negative pion | pi- | 1 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 286 | ||
| negative pion | pi- | 1 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |||
| negative pion | pi- | 1 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 94.5 | ||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 96.5 | ||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 92.5 | ||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 1.5 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 1.5 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.9 | ||
| negative pion | pi- | 1.5 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 1.5 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.3 | ||
| negative pion | pi- | 1.5 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 1.5 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 227 | ||
| negative pion | pi- | 1.5 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1.5 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1.5 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 201 | ||
| negative pion | pi- | 1.5 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1.5 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1.5 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.3 | ||
| negative pion | pi- | 1.5 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.3 | ||
| negative pion | pi- | 1.5 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.2 | ||
| negative pion | pi- | 1.5 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1.5 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65 | ||
| negative pion | pi- | 1.5 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1.5 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1.5 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.4 | ||
| negative pion | pi- | 1.5 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1.5 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1.5 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.8 | ||
| negative pion | pi- | 1.5 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1.5 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1.5 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132 | ||
| negative pion | pi- | 1.5 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 1.5 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35.7 | ||
| negative pion | pi- | 1.5 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1.5 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1.5 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.6 | ||
| negative pion | pi- | 1.5 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1.5 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.3 | ||
| negative pion | pi- | 1.5 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.7 | ||
| negative pion | pi- | 1.5 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 1.5 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.7 | ||
| negative pion | pi- | 1.5 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 1.5 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.1 | ||
| negative pion | pi- | 1.5 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1.5 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1.5 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.1 | ||
| negative pion | pi- | 1.5 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 1.5 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1.5 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.5 | ||
| negative pion | pi- | 1.5 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1.5 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.1 | ||
| negative pion | pi- | 1.5 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.3 | ||
| negative pion | pi- | 1.5 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1.5 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1.5 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.2 | ||
| negative pion | pi- | 1.5 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1.5 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1.5 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.8 | ||
| negative pion | pi- | 1.5 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1.5 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.1 | ||
| negative pion | pi- | 1.5 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1.5 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120 | ||
| negative pion | pi- | 1.5 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1.5 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 1.5 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.7 | ||
| negative pion | pi- | 1.5 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 1.5 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 1.5 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1480 | ||
| negative pion | pi- | 1.5 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 1.5 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |||
| negative pion | pi- | 1.5 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1690 | ||
| negative pion | pi- | 1.5 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 1.5 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |||
| negative pion | pi- | 1.5 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.3 | ||
| negative pion | pi- | 1.5 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1.5 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.6 | ||
| negative pion | pi- | 1.5 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.1 | ||
| negative pion | pi- | 1.5 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 1.5 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.8 | ||
| negative pion | pi- | 1.5 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 1.5 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128 | ||
| negative pion | pi- | 1.5 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 1.5 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.6 | ||
| negative pion | pi- | 1.5 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.3 | ||
| negative pion | pi- | 1.5 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 1.5 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.9 | ||
| negative pion | pi- | 1.5 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1.5 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.8 | ||
| negative pion | pi- | 1.5 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 1.5 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.1 | ||
| negative pion | pi- | 1.5 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1.5 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.9 | ||
| negative pion | pi- | 1.5 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 1.5 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1.5 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.1 | ||
| negative pion | pi- | 1.5 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 1.5 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1.5 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.5 | ||
| negative pion | pi- | 1.5 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1.5 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.6 | ||
| negative pion | pi- | 1.5 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1.5 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86 | ||
| negative pion | pi- | 1.5 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1.5 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 1.5 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.5 | ||
| negative pion | pi- | 1.5 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1.5 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 1.5 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.9 | ||
| negative pion | pi- | 1.5 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1.5 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 1.5 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.5 | ||
| negative pion | pi- | 1.5 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 1.5 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 1.5 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.1 | ||
| negative pion | pi- | 1.5 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 1.5 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 1.5 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.3 | ||
| negative pion | pi- | 1.5 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 1.5 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 1.5 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.6 | ||
| negative pion | pi- | 1.5 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 1.5 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1.5 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37 | ||
| negative pion | pi- | 1.5 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 1.5 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 1.5 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.3 | ||
| negative pion | pi- | 1.5 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1.5 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.5 | ||
| negative pion | pi- | 1.5 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 1.5 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.3 | ||
| negative pion | pi- | 1.5 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 1.5 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1.5 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.7 | ||
| negative pion | pi- | 1.5 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 1.5 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 1.5 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.1 | ||
| negative pion | pi- | 1.5 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1.5 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 1.5 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.5 | ||
| negative pion | pi- | 1.5 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 1.5 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 1.5 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 321 | ||
| negative pion | pi- | 1.5 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 1.5 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |||
| negative pion | pi- | 1.5 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 321 | ||
| negative pion | pi- | 1.5 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 1.5 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 99.1 | ||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 102 | ||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 96.7 | ||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 2 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 2 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57 | ||
| negative pion | pi- | 2 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 2 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.5 | ||
| negative pion | pi- | 2 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 2 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 243 | ||
| negative pion | pi- | 2 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 2 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 2 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 211 | ||
| negative pion | pi- | 2 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 2 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.7 | ||
| negative pion | pi- | 2 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 2 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.1 | ||
| negative pion | pi- | 2 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 2 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.9 | ||
| negative pion | pi- | 2 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 2 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 2 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66 | ||
| negative pion | pi- | 2 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 2 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.5 | ||
| negative pion | pi- | 2 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 2 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.8 | ||
| negative pion | pi- | 2 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 2 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138 | ||
| negative pion | pi- | 2 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 2 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.1 | ||
| negative pion | pi- | 2 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 2 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.4 | ||
| negative pion | pi- | 2 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 2 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.4 | ||
| negative pion | pi- | 2 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 2 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47 | ||
| negative pion | pi- | 2 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 2 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.3 | ||
| negative pion | pi- | 2 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 2 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.1 | ||
| negative pion | pi- | 2 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.3 | ||
| negative pion | pi- | 2 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.7 | ||
| negative pion | pi- | 2 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 2 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.3 | ||
| negative pion | pi- | 2 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.7 | ||
| negative pion | pi- | 2 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 2 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 2 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.5 | ||
| negative pion | pi- | 2 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 2 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 2 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.6 | ||
| negative pion | pi- | 2 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 2 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.8 | ||
| negative pion | pi- | 2 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 2 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 2 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123 | ||
| negative pion | pi- | 2 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 2 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 2 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.5 | ||
| negative pion | pi- | 2 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 2 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 2 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1650 | ||
| negative pion | pi- | 2 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |||
| negative pion | pi- | 2 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 2 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1890 | ||
| negative pion | pi- | 2 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |||
| negative pion | pi- | 2 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 2 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61 | ||
| negative pion | pi- | 2 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 2 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.8 | ||
| negative pion | pi- | 2 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 2 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.2 | ||
| negative pion | pi- | 2 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 2 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.8 | ||
| negative pion | pi- | 2 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 2 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133 | ||
| negative pion | pi- | 2 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 2 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 2 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.4 | ||
| negative pion | pi- | 2 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 2 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.2 | ||
| negative pion | pi- | 2 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 2 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.6 | ||
| negative pion | pi- | 2 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 2 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.7 | ||
| negative pion | pi- | 2 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 2 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.3 | ||
| negative pion | pi- | 2 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 2 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.1 | ||
| negative pion | pi- | 2 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 2 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 2 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.9 | ||
| negative pion | pi- | 2 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 2 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 2 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.1 | ||
| negative pion | pi- | 2 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.5 | ||
| negative pion | pi- | 2 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.6 | ||
| negative pion | pi- | 2 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 2 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 2 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.2 | ||
| negative pion | pi- | 2 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 2 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.1 | ||
| negative pion | pi- | 2 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 2 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 2 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.1 | ||
| negative pion | pi- | 2 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 2 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 2 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37 | ||
| negative pion | pi- | 2 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 2 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 2 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.5 | ||
| negative pion | pi- | 2 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 2 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 2 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.2 | ||
| negative pion | pi- | 2 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 2 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.4 | ||
| negative pion | pi- | 2 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 2 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 2 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.4 | ||
| negative pion | pi- | 2 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 2 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.8 | ||
| negative pion | pi- | 2 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 2 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.3 | ||
| negative pion | pi- | 2 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 2 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.7 | ||
| negative pion | pi- | 2 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 2 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 2 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.6 | ||
| negative pion | pi- | 2 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 2 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 2 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.9 | ||
| negative pion | pi- | 2 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 2 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 2 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 345 | ||
| negative pion | pi- | 2 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |||
| negative pion | pi- | 2 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 2 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 345 | ||
| negative pion | pi- | 2 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |||
| negative pion | pi- | 2 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 108 | ||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 111 | ||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 104 | ||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 3 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 3 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.4 | ||
| negative pion | pi- | 3 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 3 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.3 | ||
| negative pion | pi- | 3 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 3 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 281 | ||
| negative pion | pi- | 3 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 3 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 3 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 235 | ||
| negative pion | pi- | 3 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 3 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59 | ||
| negative pion | pi- | 3 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 3 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 3 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.9 | ||
| negative pion | pi- | 3 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 3 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 3 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.8 | ||
| negative pion | pi- | 3 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 3 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 3 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67 | ||
| negative pion | pi- | 3 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 3 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.3 | ||
| negative pion | pi- | 3 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61 | ||
| negative pion | pi- | 3 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 3 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 3 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 152 | ||
| negative pion | pi- | 3 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 3 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.5 | ||
| negative pion | pi- | 3 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 3 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.2 | ||
| negative pion | pi- | 3 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 3 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 3 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.5 | ||
| negative pion | pi- | 3 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 3 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 3 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45 | ||
| negative pion | pi- | 3 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 3 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.7 | ||
| negative pion | pi- | 3 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 3 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.8 | ||
| negative pion | pi- | 3 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 3 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.7 | ||
| negative pion | pi- | 3 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 3 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.5 | ||
| negative pion | pi- | 3 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 3 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.8 | ||
| negative pion | pi- | 3 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 3 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.9 | ||
| negative pion | pi- | 3 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 3 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.7 | ||
| negative pion | pi- | 3 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 3 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.1 | ||
| negative pion | pi- | 3 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 3 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 3 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.6 | ||
| negative pion | pi- | 3 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 3 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130 | ||
| negative pion | pi- | 3 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 3 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 3 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 | ||
| negative pion | pi- | 3 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 3 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 3 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1900 | ||
| negative pion | pi- | 3 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |||
| negative pion | pi- | 3 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 3 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2190 | ||
| negative pion | pi- | 3 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |||
| negative pion | pi- | 3 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 3 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.7 | ||
| negative pion | pi- | 3 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 3 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.2 | ||
| negative pion | pi- | 3 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 3 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 3 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44 | ||
| negative pion | pi- | 3 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 3 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.6 | ||
| negative pion | pi- | 3 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 3 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143 | ||
| negative pion | pi- | 3 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 3 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 3 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.8 | ||
| negative pion | pi- | 3 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 3 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47 | ||
| negative pion | pi- | 3 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 3 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.8 | ||
| negative pion | pi- | 3 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 3 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49 | ||
| negative pion | pi- | 3 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 3 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.5 | ||
| negative pion | pi- | 3 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 3 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.3 | ||
| negative pion | pi- | 3 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.6 | ||
| negative pion | pi- | 3 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.9 | ||
| negative pion | pi- | 3 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 3 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 3 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.5 | ||
| negative pion | pi- | 3 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 3 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 3 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93 | ||
| negative pion | pi- | 3 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 3 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 3 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.8 | ||
| negative pion | pi- | 3 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 3 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 3 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.4 | ||
| negative pion | pi- | 3 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 3 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 3 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.4 | ||
| negative pion | pi- | 3 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 3 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 3 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.7 | ||
| negative pion | pi- | 3 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 3 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 3 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.3 | ||
| negative pion | pi- | 3 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 3 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 3 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.5 | ||
| negative pion | pi- | 3 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 3 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 3 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.5 | ||
| negative pion | pi- | 3 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 3 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 3 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.4 | ||
| negative pion | pi- | 3 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 3 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.1 | ||
| negative pion | pi- | 3 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 3 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 3 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.8 | ||
| negative pion | pi- | 3 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 3 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 3 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63 | ||
| negative pion | pi- | 3 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 3 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 3 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.5 | ||
| negative pion | pi- | 3 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 3 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 3 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.2 | ||
| negative pion | pi- | 3 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 3 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 3 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 373 | ||
| negative pion | pi- | 3 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |||
| negative pion | pi- | 3 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 3 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 373 | ||
| negative pion | pi- | 3 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |||
| negative pion | pi- | 3 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 116 | ||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 121 | ||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 111 | ||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 4 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 4 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.6 | ||
| negative pion | pi- | 4 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.1 | ||
| negative pion | pi- | 4 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 324 | ||
| negative pion | pi- | 4 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 4 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 4 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 270 | ||
| negative pion | pi- | 4 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 4 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 4 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.7 | ||
| negative pion | pi- | 4 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 4 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 4 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.5 | ||
| negative pion | pi- | 4 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 4 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 4 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.4 | ||
| negative pion | pi- | 4 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 4 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 4 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.8 | ||
| negative pion | pi- | 4 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 4 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 4 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.6 | ||
| negative pion | pi- | 4 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 4 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.9 | ||
| negative pion | pi- | 4 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 4 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 166 | ||
| negative pion | pi- | 4 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 4 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 4 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.4 | ||
| negative pion | pi- | 4 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 4 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.3 | ||
| negative pion | pi- | 4 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 4 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.5 | ||
| negative pion | pi- | 4 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 4 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.4 | ||
| negative pion | pi- | 4 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 4 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 4 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.6 | ||
| negative pion | pi- | 4 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 4 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 4 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.9 | ||
| negative pion | pi- | 4 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 4 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 4 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.5 | ||
| negative pion | pi- | 4 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 4 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 4 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.9 | ||
| negative pion | pi- | 4 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 4 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.3 | ||
| negative pion | pi- | 4 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 4 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86 | ||
| negative pion | pi- | 4 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 4 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 4 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.3 | ||
| negative pion | pi- | 4 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 4 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 4 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.3 | ||
| negative pion | pi- | 4 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 4 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 4 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.1 | ||
| negative pion | pi- | 4 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 4 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 4 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139 | ||
| negative pion | pi- | 4 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 4 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 4 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109 | ||
| negative pion | pi- | 4 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 4 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 4 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2070 | ||
| negative pion | pi- | 4 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 4 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |||
| negative pion | pi- | 4 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2340 | ||
| negative pion | pi- | 4 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 4 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |||
| negative pion | pi- | 4 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.7 | ||
| negative pion | pi- | 4 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 4 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 4 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.3 | ||
| negative pion | pi- | 4 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 4 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 4 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.5 | ||
| negative pion | pi- | 4 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 4 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.8 | ||
| negative pion | pi- | 4 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 4 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156 | ||
| negative pion | pi- | 4 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 4 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 4 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.6 | ||
| negative pion | pi- | 4 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 4 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 4 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.1 | ||
| negative pion | pi- | 4 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 4 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49 | ||
| negative pion | pi- | 4 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 4 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.4 | ||
| negative pion | pi- | 4 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 4 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 4 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.9 | ||
| negative pion | pi- | 4 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 4 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51 | ||
| negative pion | pi- | 4 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 4 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 4 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.7 | ||
| negative pion | pi- | 4 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 4 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 4 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84.2 | ||
| negative pion | pi- | 4 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 4 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 4 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.2 | ||
| negative pion | pi- | 4 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 4 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 4 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.2 | ||
| negative pion | pi- | 4 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 4 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 4 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.5 | ||
| negative pion | pi- | 4 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 4 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 4 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.9 | ||
| negative pion | pi- | 4 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 4 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 4 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99 | ||
| negative pion | pi- | 4 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 4 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 4 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.8 | ||
| negative pion | pi- | 4 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 4 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 4 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.1 | ||
| negative pion | pi- | 4 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 4 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40 | ||
| negative pion | pi- | 4 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 4 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 4 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.9 | ||
| negative pion | pi- | 4 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 4 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 4 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.8 | ||
| negative pion | pi- | 4 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 4 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53 | ||
| negative pion | pi- | 4 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 4 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 4 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.9 | ||
| negative pion | pi- | 4 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 4 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 4 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.7 | ||
| negative pion | pi- | 4 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 4 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 4 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.6 | ||
| negative pion | pi- | 4 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 4 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 4 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.1 | ||
| negative pion | pi- | 4 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 4 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 4 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 401 | ||
| negative pion | pi- | 4 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 4 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |||
| negative pion | pi- | 4 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 401 | ||
| negative pion | pi- | 4 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |||
| negative pion | pi- | 4 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 125 | ||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 131 | ||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 120 | ||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 5 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 5 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.7 | ||
| negative pion | pi- | 5 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.7 | ||
| negative pion | pi- | 5 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 386 | ||
| negative pion | pi- | 5 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 5 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 5 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 325 | ||
| negative pion | pi- | 5 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 5 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 5 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.6 | ||
| negative pion | pi- | 5 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 5 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.7 | ||
| negative pion | pi- | 5 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 5 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.5 | ||
| negative pion | pi- | 5 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 5 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.7 | ||
| negative pion | pi- | 5 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 5 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 5 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.5 | ||
| negative pion | pi- | 5 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 5 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 5 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.7 | ||
| negative pion | pi- | 5 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 5 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177 | ||
| negative pion | pi- | 5 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 5 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 5 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.9 | ||
| negative pion | pi- | 5 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |||
| negative pion | pi- | 5 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 5 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.2 | ||
| negative pion | pi- | 5 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 5 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.8 | ||
| negative pion | pi- | 5 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 5 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.3 | ||
| negative pion | pi- | 5 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 5 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 5 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.9 | ||
| negative pion | pi- | 5 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 5 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 5 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.5 | ||
| negative pion | pi- | 5 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 5 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 5 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.2 | ||
| negative pion | pi- | 5 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 5 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 5 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.7 | ||
| negative pion | pi- | 5 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 5 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.2 | ||
| negative pion | pi- | 5 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 5 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 5 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.1 | ||
| negative pion | pi- | 5 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 5 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 5 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.8 | ||
| negative pion | pi- | 5 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 5 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 5 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.6 | ||
| negative pion | pi- | 5 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 5 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 5 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.6 | ||
| negative pion | pi- | 5 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 5 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 5 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148 | ||
| negative pion | pi- | 5 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 5 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 5 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115 | ||
| negative pion | pi- | 5 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 5 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 5 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2130 | ||
| negative pion | pi- | 5 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |||
| negative pion | pi- | 5 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |||
| negative pion | pi- | 5 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2390 | ||
| negative pion | pi- | 5 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |||
| negative pion | pi- | 5 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |||
| negative pion | pi- | 5 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.4 | ||
| negative pion | pi- | 5 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 5 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 5 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.7 | ||
| negative pion | pi- | 5 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 5 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 5 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.3 | ||
| negative pion | pi- | 5 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 5 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 5 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.1 | ||
| negative pion | pi- | 5 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 5 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 5 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173 | ||
| negative pion | pi- | 5 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 5 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 5 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102 | ||
| negative pion | pi- | 5 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 5 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 5 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.4 | ||
| negative pion | pi- | 5 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 5 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 5 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.2 | ||
| negative pion | pi- | 5 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 5 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 5 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50 | ||
| negative pion | pi- | 5 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 5 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 5 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.2 | ||
| negative pion | pi- | 5 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 5 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 5 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.3 | ||
| negative pion | pi- | 5 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 5 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 5 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.7 | ||
| negative pion | pi- | 5 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 5 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 5 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.2 | ||
| negative pion | pi- | 5 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 5 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 5 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.7 | ||
| negative pion | pi- | 5 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 5 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 5 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101 | ||
| negative pion | pi- | 5 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 5 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 5 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.1 | ||
| negative pion | pi- | 5 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 5 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 5 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.9 | ||
| negative pion | pi- | 5 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 5 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 5 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.3 | ||
| negative pion | pi- | 5 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 5 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 5 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.8 | ||
| negative pion | pi- | 5 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 5 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 5 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.7 | ||
| negative pion | pi- | 5 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 5 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 5 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.4 | ||
| negative pion | pi- | 5 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 5 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 5 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45 | ||
| negative pion | pi- | 5 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 5 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 5 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.4 | ||
| negative pion | pi- | 5 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 5 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 5 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.6 | ||
| negative pion | pi- | 5 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 5 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 5 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.1 | ||
| negative pion | pi- | 5 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 5 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 5 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64 | ||
| negative pion | pi- | 5 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 5 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 5 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75 | ||
| negative pion | pi- | 5 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 5 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 5 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.8 | ||
| negative pion | pi- | 5 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 5 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 5 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| negative pion | pi- | 5 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |||
| negative pion | pi- | 5 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |||
| negative pion | pi- | 5 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| negative pion | pi- | 5 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |||
| negative pion | pi- | 5 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 135 | ||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 145 | ||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 126 | ||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 6 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 6 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.7 | ||
| negative pion | pi- | 6 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 6 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.4 | ||
| negative pion | pi- | 6 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 6 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| negative pion | pi- | 6 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 6 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 6 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| negative pion | pi- | 6 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 6 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |||
| negative pion | pi- | 6 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.4 | ||
| negative pion | pi- | 6 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 6 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 6 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.5 | ||
| negative pion | pi- | 6 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 6 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 6 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.4 | ||
| negative pion | pi- | 6 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 6 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 6 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.5 | ||
| negative pion | pi- | 6 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 6 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 6 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54 | ||
| negative pion | pi- | 6 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 6 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.1 | ||
| negative pion | pi- | 6 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 6 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 6 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 191 | ||
| negative pion | pi- | 6 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 6 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 6 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.4 | ||
| negative pion | pi- | 6 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |||
| negative pion | pi- | 6 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 6 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.1 | ||
| negative pion | pi- | 6 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 6 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.1 | ||
| negative pion | pi- | 6 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 6 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 6 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.3 | ||
| negative pion | pi- | 6 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 6 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.6 | ||
| negative pion | pi- | 6 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 6 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.4 | ||
| negative pion | pi- | 6 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 6 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 6 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.8 | ||
| negative pion | pi- | 6 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 6 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 6 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47 | ||
| negative pion | pi- | 6 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 6 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.4 | ||
| negative pion | pi- | 6 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 6 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 6 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.6 | ||
| negative pion | pi- | 6 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 6 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 6 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.6 | ||
| negative pion | pi- | 6 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 6 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 6 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.9 | ||
| negative pion | pi- | 6 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 6 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 6 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.3 | ||
| negative pion | pi- | 6 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 6 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 6 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 163 | ||
| negative pion | pi- | 6 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 6 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 6 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123 | ||
| negative pion | pi- | 6 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 6 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 6 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2170 | ||
| negative pion | pi- | 6 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |||
| negative pion | pi- | 6 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |||
| negative pion | pi- | 6 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2100 | ||
| negative pion | pi- | 6 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |||
| negative pion | pi- | 6 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |||
| negative pion | pi- | 6 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.8 | ||
| negative pion | pi- | 6 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 6 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 6 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.3 | ||
| negative pion | pi- | 6 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 6 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 6 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.7 | ||
| negative pion | pi- | 6 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 6 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 6 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57 | ||
| negative pion | pi- | 6 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 6 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 6 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 193 | ||
| negative pion | pi- | 6 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 6 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 6 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110 | ||
| negative pion | pi- | 6 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 6 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 6 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.5 | ||
| negative pion | pi- | 6 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 6 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 6 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.1 | ||
| negative pion | pi- | 6 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 6 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 6 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.8 | ||
| negative pion | pi- | 6 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 6 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 6 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.4 | ||
| negative pion | pi- | 6 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 6 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 6 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51 | ||
| negative pion | pi- | 6 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 6 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.4 | ||
| negative pion | pi- | 6 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 6 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94.5 | ||
| negative pion | pi- | 6 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 6 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 6 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.6 | ||
| negative pion | pi- | 6 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 6 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 6 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107 | ||
| negative pion | pi- | 6 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 6 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 6 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89 | ||
| negative pion | pi- | 6 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 6 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 6 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.3 | ||
| negative pion | pi- | 6 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 6 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 6 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.4 | ||
| negative pion | pi- | 6 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 6 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 6 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.6 | ||
| negative pion | pi- | 6 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 6 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 6 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.4 | ||
| negative pion | pi- | 6 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 6 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 6 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.6 | ||
| negative pion | pi- | 6 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 6 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.5 | ||
| negative pion | pi- | 6 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 6 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 6 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.7 | ||
| negative pion | pi- | 6 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 6 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.1 | ||
| negative pion | pi- | 6 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 6 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 6 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.6 | ||
| negative pion | pi- | 6 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 6 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 6 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.1 | ||
| negative pion | pi- | 6 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 6 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 6 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.5 | ||
| negative pion | pi- | 6 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 6 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 6 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.5 | ||
| negative pion | pi- | 6 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 6 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 6 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 6 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |||
| negative pion | pi- | 6 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |||
| negative pion | pi- | 6 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 6 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |||
| negative pion | pi- | 6 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 159 | ||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 176 | ||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 141 | ||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 8 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 8 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.6 | ||
| negative pion | pi- | 8 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 8 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.1 | ||
| negative pion | pi- | 8 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 8 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 730 | ||
| negative pion | pi- | 8 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 8 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |||
| negative pion | pi- | 8 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| negative pion | pi- | 8 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 8 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |||
| negative pion | pi- | 8 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.2 | ||
| negative pion | pi- | 8 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 8 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.6 | ||
| negative pion | pi- | 8 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 8 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64 | ||
| negative pion | pi- | 8 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 8 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 8 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.6 | ||
| negative pion | pi- | 8 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 8 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 8 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.6 | ||
| negative pion | pi- | 8 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 8 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.8 | ||
| negative pion | pi- | 8 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 8 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 8 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 240 | ||
| negative pion | pi- | 8 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |||
| negative pion | pi- | 8 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 8 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39 | ||
| negative pion | pi- | 8 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |||
| negative pion | pi- | 8 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 8 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.5 | ||
| negative pion | pi- | 8 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 8 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.2 | ||
| negative pion | pi- | 8 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 8 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.5 | ||
| negative pion | pi- | 8 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 8 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.4 | ||
| negative pion | pi- | 8 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 8 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94.4 | ||
| negative pion | pi- | 8 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 8 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 8 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.7 | ||
| negative pion | pi- | 8 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 8 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 8 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.8 | ||
| negative pion | pi- | 8 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 8 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 8 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82 | ||
| negative pion | pi- | 8 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 8 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 8 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100 | ||
| negative pion | pi- | 8 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 8 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 8 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95.5 | ||
| negative pion | pi- | 8 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 8 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 8 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.8 | ||
| negative pion | pi- | 8 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 8 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 8 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.2 | ||
| negative pion | pi- | 8 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 8 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 8 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 216 | ||
| negative pion | pi- | 8 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 8 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 8 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139 | ||
| negative pion | pi- | 8 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 8 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 8 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1540 | ||
| negative pion | pi- | 8 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 8 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 8 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| negative pion | pi- | 8 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 8 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 8 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.1 | ||
| negative pion | pi- | 8 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 8 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 8 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.1 | ||
| negative pion | pi- | 8 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 8 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 8 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.3 | ||
| negative pion | pi- | 8 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 8 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 8 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.1 | ||
| negative pion | pi- | 8 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 8 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 8 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 241 | ||
| negative pion | pi- | 8 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |||
| negative pion | pi- | 8 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 8 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123 | ||
| negative pion | pi- | 8 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 8 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.5 | ||
| negative pion | pi- | 8 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 8 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.8 | ||
| negative pion | pi- | 8 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 8 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.4 | ||
| negative pion | pi- | 8 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 8 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.7 | ||
| negative pion | pi- | 8 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 8 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 8 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.3 | ||
| negative pion | pi- | 8 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 8 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.4 | ||
| negative pion | pi- | 8 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 8 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117 | ||
| negative pion | pi- | 8 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 8 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 8 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.2 | ||
| negative pion | pi- | 8 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 8 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 8 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121 | ||
| negative pion | pi- | 8 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 8 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 8 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96 | ||
| negative pion | pi- | 8 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 8 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 8 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.7 | ||
| negative pion | pi- | 8 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 8 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 8 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100 | ||
| negative pion | pi- | 8 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 8 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 8 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.2 | ||
| negative pion | pi- | 8 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 8 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 8 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.1 | ||
| negative pion | pi- | 8 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 8 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 8 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.5 | ||
| negative pion | pi- | 8 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 8 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 8 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.4 | ||
| negative pion | pi- | 8 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 8 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 8 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.8 | ||
| negative pion | pi- | 8 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58 | ||
| negative pion | pi- | 8 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 8 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.8 | ||
| negative pion | pi- | 8 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 8 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 8 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.8 | ||
| negative pion | pi- | 8 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 8 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 8 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.6 | ||
| negative pion | pi- | 8 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 8 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 8 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.4 | ||
| negative pion | pi- | 8 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 8 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 8 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 894 | ||
| negative pion | pi- | 8 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 8 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 8 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 894 | ||
| negative pion | pi- | 8 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 8 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 181 | ||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 207 | ||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 155 | ||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 10 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 10 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.4 | ||
| negative pion | pi- | 10 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 10 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.1 | ||
| negative pion | pi- | 10 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 10 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 939 | ||
| negative pion | pi- | 10 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |||
| negative pion | pi- | 10 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |||
| negative pion | pi- | 10 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 664 | ||
| negative pion | pi- | 10 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |||
| negative pion | pi- | 10 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |||
| negative pion | pi- | 10 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.1 | ||
| negative pion | pi- | 10 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 10 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 10 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.6 | ||
| negative pion | pi- | 10 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 10 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 10 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.6 | ||
| negative pion | pi- | 10 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 10 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 10 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.1 | ||
| negative pion | pi- | 10 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 10 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 10 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56 | ||
| negative pion | pi- | 10 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 10 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 10 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.1 | ||
| negative pion | pi- | 10 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 10 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 10 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 294 | ||
| negative pion | pi- | 10 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |||
| negative pion | pi- | 10 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 10 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.8 | ||
| negative pion | pi- | 10 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |||
| negative pion | pi- | 10 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 10 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60 | ||
| negative pion | pi- | 10 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 10 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 10 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.7 | ||
| negative pion | pi- | 10 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 10 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 10 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.5 | ||
| negative pion | pi- | 10 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 10 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 10 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.3 | ||
| negative pion | pi- | 10 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 10 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 10 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102 | ||
| negative pion | pi- | 10 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 10 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 10 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110 | ||
| negative pion | pi- | 10 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 10 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 10 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.2 | ||
| negative pion | pi- | 10 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 10 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 10 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.8 | ||
| negative pion | pi- | 10 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 10 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 10 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116 | ||
| negative pion | pi- | 10 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 10 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 10 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111 | ||
| negative pion | pi- | 10 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 10 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 10 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.6 | ||
| negative pion | pi- | 10 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 10 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 10 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.8 | ||
| negative pion | pi- | 10 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 10 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 10 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 301 | ||
| negative pion | pi- | 10 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 10 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 10 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 158 | ||
| negative pion | pi- | 10 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 10 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 10 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| negative pion | pi- | 10 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 10 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 10 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 10 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 10 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 10 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93 | ||
| negative pion | pi- | 10 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 10 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 10 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.4 | ||
| negative pion | pi- | 10 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 10 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 10 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.4 | ||
| negative pion | pi- | 10 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 10 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 10 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.8 | ||
| negative pion | pi- | 10 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 10 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 10 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 290 | ||
| negative pion | pi- | 10 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |||
| negative pion | pi- | 10 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 10 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136 | ||
| negative pion | pi- | 10 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 10 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 10 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.5 | ||
| negative pion | pi- | 10 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 10 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.2 | ||
| negative pion | pi- | 10 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 10 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.2 | ||
| negative pion | pi- | 10 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 10 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.8 | ||
| negative pion | pi- | 10 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 10 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.2 | ||
| negative pion | pi- | 10 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 10 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.9 | ||
| negative pion | pi- | 10 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 10 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145 | ||
| negative pion | pi- | 10 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 10 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.7 | ||
| negative pion | pi- | 10 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 10 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 146 | ||
| negative pion | pi- | 10 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 10 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 10 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108 | ||
| negative pion | pi- | 10 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 10 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 10 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100 | ||
| negative pion | pi- | 10 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 10 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 10 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116 | ||
| negative pion | pi- | 10 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 10 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 10 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.1 | ||
| negative pion | pi- | 10 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 10 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 10 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.1 | ||
| negative pion | pi- | 10 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 10 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 10 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.1 | ||
| negative pion | pi- | 10 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 10 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 10 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.5 | ||
| negative pion | pi- | 10 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 10 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 10 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.6 | ||
| negative pion | pi- | 10 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 10 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.1 | ||
| negative pion | pi- | 10 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 10 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.5 | ||
| negative pion | pi- | 10 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 10 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 10 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.9 | ||
| negative pion | pi- | 10 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 10 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 10 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102 | ||
| negative pion | pi- | 10 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 10 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 10 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.1 | ||
| negative pion | pi- | 10 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 10 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 10 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 10 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 10 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 10 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 10 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 10 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 220 | ||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 249 | ||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 191 | ||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 15 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 15 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114 | ||
| negative pion | pi- | 15 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 15 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 15 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120 | ||
| negative pion | pi- | 15 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 15 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 15 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 15 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 15 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |||
| negative pion | pi- | 15 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 803 | ||
| negative pion | pi- | 15 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |||
| negative pion | pi- | 15 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 15 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.8 | ||
| negative pion | pi- | 15 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 15 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 15 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.2 | ||
| negative pion | pi- | 15 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 15 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 15 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73 | ||
| negative pion | pi- | 15 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 15 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 15 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.5 | ||
| negative pion | pi- | 15 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 15 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 15 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.7 | ||
| negative pion | pi- | 15 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 15 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 15 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.8 | ||
| negative pion | pi- | 15 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 15 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 15 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 15 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |||
| negative pion | pi- | 15 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 15 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.6 | ||
| negative pion | pi- | 15 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |||
| negative pion | pi- | 15 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 15 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.2 | ||
| negative pion | pi- | 15 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 15 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 15 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.6 | ||
| negative pion | pi- | 15 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 15 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 15 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.4 | ||
| negative pion | pi- | 15 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 15 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 15 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.4 | ||
| negative pion | pi- | 15 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 15 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 15 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 152 | ||
| negative pion | pi- | 15 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 15 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 15 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 180 | ||
| negative pion | pi- | 15 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 15 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 15 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.8 | ||
| negative pion | pi- | 15 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 15 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 15 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 153 | ||
| negative pion | pi- | 15 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 15 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 15 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 201 | ||
| negative pion | pi- | 15 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 15 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 15 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 195 | ||
| negative pion | pi- | 15 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 15 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 15 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.6 | ||
| negative pion | pi- | 15 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 15 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 15 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115 | ||
| negative pion | pi- | 15 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 15 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 15 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| negative pion | pi- | 15 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |||
| negative pion | pi- | 15 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |||
| negative pion | pi- | 15 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 346 | ||
| negative pion | pi- | 15 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |||
| negative pion | pi- | 15 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |||
| negative pion | pi- | 15 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 809 | ||
| negative pion | pi- | 15 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 15 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 15 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 795 | ||
| negative pion | pi- | 15 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 15 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 15 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126 | ||
| negative pion | pi- | 15 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 15 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 15 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113 | ||
| negative pion | pi- | 15 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 15 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 15 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.7 | ||
| negative pion | pi- | 15 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 15 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62 | ||
| negative pion | pi- | 15 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 15 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 15 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 15 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |||
| negative pion | pi- | 15 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 275 | ||
| negative pion | pi- | 15 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 15 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 15 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.3 | ||
| negative pion | pi- | 15 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 15 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.2 | ||
| negative pion | pi- | 15 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 15 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.1 | ||
| negative pion | pi- | 15 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 15 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 15 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.2 | ||
| negative pion | pi- | 15 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 15 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.5 | ||
| negative pion | pi- | 15 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 15 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62 | ||
| negative pion | pi- | 15 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 15 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 211 | ||
| negative pion | pi- | 15 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 15 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |||
| negative pion | pi- | 15 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 158 | ||
| negative pion | pi- | 15 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 15 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |||
| negative pion | pi- | 15 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 253 | ||
| negative pion | pi- | 15 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 15 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 15 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 168 | ||
| negative pion | pi- | 15 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 15 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 15 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133 | ||
| negative pion | pi- | 15 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 15 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 15 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 189 | ||
| negative pion | pi- | 15 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 15 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 15 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.5 | ||
| negative pion | pi- | 15 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 15 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 15 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120 | ||
| negative pion | pi- | 15 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 15 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 15 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.8 | ||
| negative pion | pi- | 15 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 15 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 15 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.5 | ||
| negative pion | pi- | 15 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 15 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 15 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.1 | ||
| negative pion | pi- | 15 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 15 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.2 | ||
| negative pion | pi- | 15 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 15 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.6 | ||
| negative pion | pi- | 15 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 15 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 15 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.5 | ||
| negative pion | pi- | 15 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 15 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 15 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 156 | ||
| negative pion | pi- | 15 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 15 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 15 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113 | ||
| negative pion | pi- | 15 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 15 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 15 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 983 | ||
| negative pion | pi- | 15 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 15 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 15 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 983 | ||
| negative pion | pi- | 15 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 15 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 255 | ||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 275 | ||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 235 | ||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 20 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 20 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172 | ||
| negative pion | pi- | 20 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 20 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 20 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 174 | ||
| negative pion | pi- | 20 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 20 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 20 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 20 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 20 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 20 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 812 | ||
| negative pion | pi- | 20 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 20 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 20 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101 | ||
| negative pion | pi- | 20 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 20 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111 | ||
| negative pion | pi- | 20 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 20 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.3 | ||
| negative pion | pi- | 20 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 20 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110 | ||
| negative pion | pi- | 20 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 20 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 20 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.1 | ||
| negative pion | pi- | 20 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 20 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 20 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117 | ||
| negative pion | pi- | 20 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 20 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 20 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| negative pion | pi- | 20 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 20 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 20 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.1 | ||
| negative pion | pi- | 20 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |||
| negative pion | pi- | 20 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 20 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.4 | ||
| negative pion | pi- | 20 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 20 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 20 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108 | ||
| negative pion | pi- | 20 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 20 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.1 | ||
| negative pion | pi- | 20 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 20 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 20 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.8 | ||
| negative pion | pi- | 20 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 20 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 20 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 360 | ||
| negative pion | pi- | 20 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 20 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |||
| negative pion | pi- | 20 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| negative pion | pi- | 20 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 20 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |||
| negative pion | pi- | 20 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.8 | ||
| negative pion | pi- | 20 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 20 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 20 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 275 | ||
| negative pion | pi- | 20 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |||
| negative pion | pi- | 20 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |||
| negative pion | pi- | 20 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 329 | ||
| negative pion | pi- | 20 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 20 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 20 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 311 | ||
| negative pion | pi- | 20 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 20 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 20 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 158 | ||
| negative pion | pi- | 20 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 20 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 20 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 204 | ||
| negative pion | pi- | 20 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 20 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 20 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 705 | ||
| negative pion | pi- | 20 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |||
| negative pion | pi- | 20 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 20 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| negative pion | pi- | 20 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |||
| negative pion | pi- | 20 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 20 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 664 | ||
| negative pion | pi- | 20 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 20 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 20 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 658 | ||
| negative pion | pi- | 20 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 20 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 20 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161 | ||
| negative pion | pi- | 20 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 20 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 20 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 153 | ||
| negative pion | pi- | 20 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 20 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 20 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.9 | ||
| negative pion | pi- | 20 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 20 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.4 | ||
| negative pion | pi- | 20 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 20 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| negative pion | pi- | 20 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 20 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 20 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 309 | ||
| negative pion | pi- | 20 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 20 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 20 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.6 | ||
| negative pion | pi- | 20 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 20 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.4 | ||
| negative pion | pi- | 20 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.9 | ||
| negative pion | pi- | 20 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 20 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.2 | ||
| negative pion | pi- | 20 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 20 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.2 | ||
| negative pion | pi- | 20 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 20 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.6 | ||
| negative pion | pi- | 20 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 20 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 247 | ||
| negative pion | pi- | 20 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 20 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 20 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 243 | ||
| negative pion | pi- | 20 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 20 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 20 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 375 | ||
| negative pion | pi- | 20 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 20 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 20 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 273 | ||
| negative pion | pi- | 20 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 20 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 20 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 183 | ||
| negative pion | pi- | 20 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 20 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 20 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 256 | ||
| negative pion | pi- | 20 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 20 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 20 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.6 | ||
| negative pion | pi- | 20 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 20 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 20 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 174 | ||
| negative pion | pi- | 20 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 20 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 20 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.8 | ||
| negative pion | pi- | 20 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 20 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.7 | ||
| negative pion | pi- | 20 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 20 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 20 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.1 | ||
| negative pion | pi- | 20 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 20 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.4 | ||
| negative pion | pi- | 20 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 20 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 20 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.8 | ||
| negative pion | pi- | 20 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 20 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 20 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94 | ||
| negative pion | pi- | 20 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 20 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 20 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 249 | ||
| negative pion | pi- | 20 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 20 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 20 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 205 | ||
| negative pion | pi- | 20 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 20 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 20 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 798 | ||
| negative pion | pi- | 20 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 20 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 20 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 798 | ||
| negative pion | pi- | 20 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 20 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 339 | ||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 343 | ||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 334 | ||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 30 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 30 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 273 | ||
| negative pion | pi- | 30 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 30 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 30 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 285 | ||
| negative pion | pi- | 30 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 30 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 30 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 721 | ||
| negative pion | pi- | 30 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 30 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 30 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 678 | ||
| negative pion | pi- | 30 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 30 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 30 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 292 | ||
| negative pion | pi- | 30 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 30 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 30 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 297 | ||
| negative pion | pi- | 30 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 30 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 30 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 232 | ||
| negative pion | pi- | 30 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 30 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 291 | ||
| negative pion | pi- | 30 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 30 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194 | ||
| negative pion | pi- | 30 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 30 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 30 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 284 | ||
| negative pion | pi- | 30 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 30 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |||
| negative pion | pi- | 30 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| negative pion | pi- | 30 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 30 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.2 | ||
| negative pion | pi- | 30 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |||
| negative pion | pi- | 30 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 30 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 190 | ||
| negative pion | pi- | 30 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |||
| negative pion | pi- | 30 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 30 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 257 | ||
| negative pion | pi- | 30 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 30 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 30 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 180 | ||
| negative pion | pi- | 30 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 30 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 30 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198 | ||
| negative pion | pi- | 30 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 30 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 30 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 570 | ||
| negative pion | pi- | 30 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 30 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 594 | ||
| negative pion | pi- | 30 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 30 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154 | ||
| negative pion | pi- | 30 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 30 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 30 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 314 | ||
| negative pion | pi- | 30 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 30 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 30 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 30 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 30 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| negative pion | pi- | 30 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 30 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| negative pion | pi- | 30 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 30 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 30 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| negative pion | pi- | 30 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 30 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 30 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 638 | ||
| negative pion | pi- | 30 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 30 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 30 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| negative pion | pi- | 30 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 30 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 30 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 560 | ||
| negative pion | pi- | 30 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 30 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 30 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 | ||
| negative pion | pi- | 30 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 30 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 30 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 244 | ||
| negative pion | pi- | 30 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 30 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 259 | ||
| negative pion | pi- | 30 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 30 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 30 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79 | ||
| negative pion | pi- | 30 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 30 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.7 | ||
| negative pion | pi- | 30 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 30 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| negative pion | pi- | 30 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 30 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 30 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 354 | ||
| negative pion | pi- | 30 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 30 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124 | ||
| negative pion | pi- | 30 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |||
| negative pion | pi- | 30 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.7 | ||
| negative pion | pi- | 30 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 30 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 169 | ||
| negative pion | pi- | 30 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 30 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 30 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 213 | ||
| negative pion | pi- | 30 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |||
| negative pion | pi- | 30 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 30 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.5 | ||
| negative pion | pi- | 30 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 30 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 30 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116 | ||
| negative pion | pi- | 30 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 30 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 30 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 294 | ||
| negative pion | pi- | 30 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 30 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 30 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 288 | ||
| negative pion | pi- | 30 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 30 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 30 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| negative pion | pi- | 30 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 30 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 30 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| negative pion | pi- | 30 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 30 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 348 | ||
| negative pion | pi- | 30 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 30 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 30 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 467 | ||
| negative pion | pi- | 30 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |||
| negative pion | pi- | 30 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 30 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.4 | ||
| negative pion | pi- | 30 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 30 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 30 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 285 | ||
| negative pion | pi- | 30 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 30 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 30 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.4 | ||
| negative pion | pi- | 30 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 30 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 30 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.5 | ||
| negative pion | pi- | 30 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 30 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 30 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165 | ||
| negative pion | pi- | 30 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 30 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 190 | ||
| negative pion | pi- | 30 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 30 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 30 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 165 | ||
| negative pion | pi- | 30 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 30 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 30 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 283 | ||
| negative pion | pi- | 30 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 30 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 30 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| negative pion | pi- | 30 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 30 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 30 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 437 | ||
| negative pion | pi- | 30 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |||
| negative pion | pi- | 30 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 30 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 647 | ||
| negative pion | pi- | 30 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 30 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 30 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 647 | ||
| negative pion | pi- | 30 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 30 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 434 | ||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 423 | ||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 446 | ||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 40 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 40 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 383 | ||
| negative pion | pi- | 40 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 40 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 40 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 40 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 40 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 40 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| negative pion | pi- | 40 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 40 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 40 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| negative pion | pi- | 40 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 40 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 40 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| negative pion | pi- | 40 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 40 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 40 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| negative pion | pi- | 40 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 40 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 40 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 478 | ||
| negative pion | pi- | 40 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 40 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 40 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 620 | ||
| negative pion | pi- | 40 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |||
| negative pion | pi- | 40 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |||
| negative pion | pi- | 40 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 340 | ||
| negative pion | pi- | 40 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 40 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 40 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| negative pion | pi- | 40 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 40 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 40 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| negative pion | pi- | 40 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 40 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |||
| negative pion | pi- | 40 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114 | ||
| negative pion | pi- | 40 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |||
| negative pion | pi- | 40 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 40 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 333 | ||
| negative pion | pi- | 40 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 40 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 40 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 40 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 40 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 40 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 231 | ||
| negative pion | pi- | 40 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 40 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 40 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 291 | ||
| negative pion | pi- | 40 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 40 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 40 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| negative pion | pi- | 40 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 40 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 40 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| negative pion | pi- | 40 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 40 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 40 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 302 | ||
| negative pion | pi- | 40 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 40 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 40 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 373 | ||
| negative pion | pi- | 40 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |||
| negative pion | pi- | 40 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| negative pion | pi- | 40 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 40 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 40 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 617 | ||
| negative pion | pi- | 40 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 40 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 40 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 712 | ||
| negative pion | pi- | 40 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 40 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 40 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 772 | ||
| negative pion | pi- | 40 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |||
| negative pion | pi- | 40 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |||
| negative pion | pi- | 40 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| negative pion | pi- | 40 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 40 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 40 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| negative pion | pi- | 40 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 40 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 40 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 40 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 40 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 40 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| negative pion | pi- | 40 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 40 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 40 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 367 | ||
| negative pion | pi- | 40 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 40 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 40 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 40 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 40 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 40 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 330 | ||
| negative pion | pi- | 40 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 40 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 40 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 233 | ||
| negative pion | pi- | 40 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 40 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |||
| negative pion | pi- | 40 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| negative pion | pi- | 40 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 40 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 40 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 701 | ||
| negative pion | pi- | 40 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 40 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 40 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 234 | ||
| negative pion | pi- | 40 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 40 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |||
| negative pion | pi- | 40 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181 | ||
| negative pion | pi- | 40 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 40 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 40 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 315 | ||
| negative pion | pi- | 40 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 40 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 40 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 40 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 40 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 40 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 315 | ||
| negative pion | pi- | 40 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 40 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 40 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 341 | ||
| negative pion | pi- | 40 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 40 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |||
| negative pion | pi- | 40 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 372 | ||
| negative pion | pi- | 40 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 40 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 418 | ||
| negative pion | pi- | 40 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 40 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| negative pion | pi- | 40 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 40 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 40 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 40 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 40 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 695 | ||
| negative pion | pi- | 40 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 40 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 645 | ||
| negative pion | pi- | 40 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 40 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90 | ||
| negative pion | pi- | 40 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 40 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 40 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 40 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 40 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 40 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109 | ||
| negative pion | pi- | 40 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |||
| negative pion | pi- | 40 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |||
| negative pion | pi- | 40 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150 | ||
| negative pion | pi- | 40 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 40 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 40 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 301 | ||
| negative pion | pi- | 40 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 40 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 40 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 364 | ||
| negative pion | pi- | 40 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 40 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 40 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 40 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 40 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |||
| negative pion | pi- | 40 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| negative pion | pi- | 40 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 40 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 40 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| negative pion | pi- | 40 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 40 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 40 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 40 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 40 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 40 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 591 | ||
| negative pion | pi- | 40 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 40 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 40 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 591 | ||
| negative pion | pi- | 40 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 40 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 512 | ||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 490 | ||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 533 | ||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 50 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 50 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| negative pion | pi- | 50 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 50 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| negative pion | pi- | 50 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 50 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 464 | ||
| negative pion | pi- | 50 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 50 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 50 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| negative pion | pi- | 50 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 50 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 50 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| negative pion | pi- | 50 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 50 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 50 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| negative pion | pi- | 50 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 50 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 50 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 659 | ||
| negative pion | pi- | 50 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 50 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 50 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 671 | ||
| negative pion | pi- | 50 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 50 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 50 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 459 | ||
| negative pion | pi- | 50 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 50 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 50 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| negative pion | pi- | 50 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 50 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 50 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 392 | ||
| negative pion | pi- | 50 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 50 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 50 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 50 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 50 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 50 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| negative pion | pi- | 50 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 50 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 50 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| negative pion | pi- | 50 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 50 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 50 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 50 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 50 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 620 | ||
| negative pion | pi- | 50 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |||
| negative pion | pi- | 50 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 50 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 508 | ||
| negative pion | pi- | 50 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 50 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 50 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| negative pion | pi- | 50 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 50 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 50 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 351 | ||
| negative pion | pi- | 50 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 50 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 50 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 50 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 50 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 632 | ||
| negative pion | pi- | 50 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 50 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 50 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 651 | ||
| negative pion | pi- | 50 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 50 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 50 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 805 | ||
| negative pion | pi- | 50 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 50 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 827 | ||
| negative pion | pi- | 50 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 50 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 50 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| negative pion | pi- | 50 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 50 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 50 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 624 | ||
| negative pion | pi- | 50 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 50 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 50 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| negative pion | pi- | 50 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 50 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 50 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| negative pion | pi- | 50 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 50 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 50 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| negative pion | pi- | 50 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 50 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| negative pion | pi- | 50 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 50 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 445 | ||
| negative pion | pi- | 50 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 50 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 50 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| negative pion | pi- | 50 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 50 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 50 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| negative pion | pi- | 50 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 50 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 50 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 779 | ||
| negative pion | pi- | 50 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 50 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 50 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 380 | ||
| negative pion | pi- | 50 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 50 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 488 | ||
| negative pion | pi- | 50 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 50 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| negative pion | pi- | 50 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 50 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 50 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| negative pion | pi- | 50 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 50 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| negative pion | pi- | 50 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 50 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 50 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 50 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 50 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |||
| negative pion | pi- | 50 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| negative pion | pi- | 50 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 50 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 50 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 50 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 50 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 50 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| negative pion | pi- | 50 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 50 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 50 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 625 | ||
| negative pion | pi- | 50 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 50 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 50 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 771 | ||
| negative pion | pi- | 50 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 50 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 703 | ||
| negative pion | pi- | 50 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 50 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 215 | ||
| negative pion | pi- | 50 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |||
| negative pion | pi- | 50 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 50 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| negative pion | pi- | 50 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 50 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |||
| negative pion | pi- | 50 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 388 | ||
| negative pion | pi- | 50 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 50 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |||
| negative pion | pi- | 50 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| negative pion | pi- | 50 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |||
| negative pion | pi- | 50 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |||
| negative pion | pi- | 50 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| negative pion | pi- | 50 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 50 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| negative pion | pi- | 50 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 50 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| negative pion | pi- | 50 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 50 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 50 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| negative pion | pi- | 50 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 50 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 50 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 50 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 50 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 50 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| negative pion | pi- | 50 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |||
| negative pion | pi- | 50 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |||
| negative pion | pi- | 50 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 579 | ||
| negative pion | pi- | 50 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 50 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 50 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 579 | ||
| negative pion | pi- | 50 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 50 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 573 | ||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 540 | ||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 606 | ||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 60 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| negative pion | pi- | 60 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 60 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 60 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| negative pion | pi- | 60 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 60 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 60 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 60 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 60 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 60 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| negative pion | pi- | 60 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 60 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 60 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| negative pion | pi- | 60 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 60 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 60 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| negative pion | pi- | 60 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 60 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |||
| negative pion | pi- | 60 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 658 | ||
| negative pion | pi- | 60 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 60 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 60 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 683 | ||
| negative pion | pi- | 60 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 60 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 60 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| negative pion | pi- | 60 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 60 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 60 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| negative pion | pi- | 60 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 60 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 60 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 60 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 60 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 60 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 660 | ||
| negative pion | pi- | 60 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 60 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| negative pion | pi- | 60 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| negative pion | pi- | 60 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 60 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 60 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 718 | ||
| negative pion | pi- | 60 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 60 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 60 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 764 | ||
| negative pion | pi- | 60 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 60 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 60 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| negative pion | pi- | 60 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 60 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 60 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| negative pion | pi- | 60 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 60 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 60 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| negative pion | pi- | 60 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 60 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 451 | ||
| negative pion | pi- | 60 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 60 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 60 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 615 | ||
| negative pion | pi- | 60 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 60 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 639 | ||
| negative pion | pi- | 60 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 60 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 769 | ||
| negative pion | pi- | 60 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 60 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 60 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 765 | ||
| negative pion | pi- | 60 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |||
| negative pion | pi- | 60 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 607 | ||
| negative pion | pi- | 60 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 60 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 691 | ||
| negative pion | pi- | 60 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 60 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| negative pion | pi- | 60 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 60 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 60 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 60 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 60 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 60 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| negative pion | pi- | 60 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 60 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 651 | ||
| negative pion | pi- | 60 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 60 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| negative pion | pi- | 60 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 60 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 60 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 727 | ||
| negative pion | pi- | 60 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 60 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 60 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 684 | ||
| negative pion | pi- | 60 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 60 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 60 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 673 | ||
| negative pion | pi- | 60 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 60 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 60 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| negative pion | pi- | 60 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |||
| negative pion | pi- | 60 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| negative pion | pi- | 60 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 60 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 60 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| negative pion | pi- | 60 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |||
| negative pion | pi- | 60 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |||
| negative pion | pi- | 60 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 662 | ||
| negative pion | pi- | 60 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |||
| negative pion | pi- | 60 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 60 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| negative pion | pi- | 60 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 60 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| negative pion | pi- | 60 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |||
| negative pion | pi- | 60 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| negative pion | pi- | 60 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 60 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| negative pion | pi- | 60 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 60 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| negative pion | pi- | 60 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 60 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 610 | ||
| negative pion | pi- | 60 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 60 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 687 | ||
| negative pion | pi- | 60 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 60 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 60 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 684 | ||
| negative pion | pi- | 60 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 60 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 60 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| negative pion | pi- | 60 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |||
| negative pion | pi- | 60 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |||
| negative pion | pi- | 60 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| negative pion | pi- | 60 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 60 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |||
| negative pion | pi- | 60 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 596 | ||
| negative pion | pi- | 60 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |||
| negative pion | pi- | 60 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |||
| negative pion | pi- | 60 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| negative pion | pi- | 60 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |||
| negative pion | pi- | 60 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |||
| negative pion | pi- | 60 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| negative pion | pi- | 60 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| negative pion | pi- | 60 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| negative pion | pi- | 60 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |||
| negative pion | pi- | 60 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| negative pion | pi- | 60 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |||
| negative pion | pi- | 60 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |||
| negative pion | pi- | 60 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| negative pion | pi- | 60 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 60 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 60 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 807 | ||
| negative pion | pi- | 60 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 60 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |||
| negative pion | pi- | 60 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 60 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 60 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 60 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 60 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 60 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 577 | ||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 564 | ||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 591 | ||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 80 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| negative pion | pi- | 80 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| negative pion | pi- | 80 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| negative pion | pi- | 80 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 80 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| negative pion | pi- | 80 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 80 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 80 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 80 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 80 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 80 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| negative pion | pi- | 80 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 80 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| negative pion | pi- | 80 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 80 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 80 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 579 | ||
| negative pion | pi- | 80 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |||
| negative pion | pi- | 80 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 80 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 570 | ||
| negative pion | pi- | 80 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 80 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 80 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| negative pion | pi- | 80 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 80 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 80 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| negative pion | pi- | 80 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 80 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 80 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 80 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 80 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| negative pion | pi- | 80 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 80 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 634 | ||
| negative pion | pi- | 80 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 80 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 80 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 643 | ||
| negative pion | pi- | 80 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 80 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 80 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| negative pion | pi- | 80 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 80 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| negative pion | pi- | 80 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 80 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 632 | ||
| negative pion | pi- | 80 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |||
| negative pion | pi- | 80 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 619 | ||
| negative pion | pi- | 80 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 80 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| negative pion | pi- | 80 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 80 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 80 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| negative pion | pi- | 80 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 80 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 80 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| negative pion | pi- | 80 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 80 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 80 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| negative pion | pi- | 80 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 80 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 80 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| negative pion | pi- | 80 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 80 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 603 | ||
| negative pion | pi- | 80 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 80 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| negative pion | pi- | 80 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 80 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 80 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 490 | ||
| negative pion | pi- | 80 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 80 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 80 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 80 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 80 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| negative pion | pi- | 80 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |||
| negative pion | pi- | 80 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| negative pion | pi- | 80 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 80 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 636 | ||
| negative pion | pi- | 80 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 80 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| negative pion | pi- | 80 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 80 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 80 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| negative pion | pi- | 80 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 80 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 80 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 625 | ||
| negative pion | pi- | 80 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |||
| negative pion | pi- | 80 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| negative pion | pi- | 80 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 80 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 609 | ||
| negative pion | pi- | 80 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 80 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 610 | ||
| negative pion | pi- | 80 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 80 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 80 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 568 | ||
| negative pion | pi- | 80 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 80 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 597 | ||
| negative pion | pi- | 80 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 80 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 80 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 80 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 80 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 592 | ||
| negative pion | pi- | 80 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 80 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 80 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| negative pion | pi- | 80 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 80 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 80 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| negative pion | pi- | 80 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 80 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 80 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| negative pion | pi- | 80 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 80 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| negative pion | pi- | 80 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 80 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 641 | ||
| negative pion | pi- | 80 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 80 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |||
| negative pion | pi- | 80 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| negative pion | pi- | 80 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |||
| negative pion | pi- | 80 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 80 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| negative pion | pi- | 80 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 80 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |||
| negative pion | pi- | 80 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 695 | ||
| negative pion | pi- | 80 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |||
| negative pion | pi- | 80 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |||
| negative pion | pi- | 80 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 565 | ||
| negative pion | pi- | 80 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 80 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 579 | ||
| negative pion | pi- | 80 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |||
| negative pion | pi- | 80 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 80 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| negative pion | pi- | 80 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |||
| negative pion | pi- | 80 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |||
| negative pion | pi- | 80 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| negative pion | pi- | 80 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 80 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 80 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 80 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |||
| negative pion | pi- | 80 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 617 | ||
| negative pion | pi- | 80 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |||
| negative pion | pi- | 80 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 80 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| negative pion | pi- | 80 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 80 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 80 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| negative pion | pi- | 80 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 80 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 513 | ||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 513 | ||
| negative pion | pi- | 100 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 100 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 100 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 100 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| negative pion | pi- | 100 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 100 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 100 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 515 | ||
| negative pion | pi- | 100 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 100 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| negative pion | pi- | 100 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 100 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| negative pion | pi- | 100 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| negative pion | pi- | 100 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 100 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| negative pion | pi- | 100 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 100 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| negative pion | pi- | 100 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 100 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| negative pion | pi- | 100 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 100 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 100 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| negative pion | pi- | 100 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 100 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| negative pion | pi- | 100 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |||
| negative pion | pi- | 100 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 517 | ||
| negative pion | pi- | 100 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 100 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| negative pion | pi- | 100 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 100 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| negative pion | pi- | 100 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 100 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| negative pion | pi- | 100 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 100 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| negative pion | pi- | 100 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 100 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| negative pion | pi- | 100 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 100 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 100 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| negative pion | pi- | 100 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |||
| negative pion | pi- | 100 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 100 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| negative pion | pi- | 100 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 487 | ||
| negative pion | pi- | 100 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| negative pion | pi- | 100 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 100 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 100 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 467 | ||
| negative pion | pi- | 100 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 100 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 100 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| negative pion | pi- | 100 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 100 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| negative pion | pi- | 100 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 100 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| negative pion | pi- | 100 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 457 | ||
| negative pion | pi- | 100 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| negative pion | pi- | 100 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 100 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| negative pion | pi- | 100 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 100 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| negative pion | pi- | 100 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 100 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 100 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |||
| negative pion | pi- | 100 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 100 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 100 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 100 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| negative pion | pi- | 100 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| negative pion | pi- | 100 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 100 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| negative pion | pi- | 100 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 100 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| negative pion | pi- | 100 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 100 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 515 | ||
| negative pion | pi- | 100 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| negative pion | pi- | 100 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 100 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 100 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 100 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 100 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 100 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 100 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 100 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| negative pion | pi- | 100 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 100 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| negative pion | pi- | 100 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| negative pion | pi- | 100 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| negative pion | pi- | 100 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| negative pion | pi- | 100 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |||
| negative pion | pi- | 100 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 100 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 100 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 100 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |||
| negative pion | pi- | 100 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 100 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |||
| negative pion | pi- | 100 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| negative pion | pi- | 100 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 100 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 100 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |||
| negative pion | pi- | 100 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 100 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| negative pion | pi- | 100 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |||
| negative pion | pi- | 100 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| negative pion | pi- | 100 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 100 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| negative pion | pi- | 100 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 100 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 100 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| negative pion | pi- | 100 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 100 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 100 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| negative pion | pi- | 100 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 100 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| negative pion | pi- | 100 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 100 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 150 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 150 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 150 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 150 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 418 | ||
| negative pion | pi- | 150 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 150 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 150 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 150 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 | ||
| negative pion | pi- | 150 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 | ||
| negative pion | pi- | 150 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 150 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 423 | ||
| negative pion | pi- | 150 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 436 | ||
| negative pion | pi- | 150 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 150 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 | ||
| negative pion | pi- | 150 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 421 | ||
| negative pion | pi- | 150 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| negative pion | pi- | 150 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 150 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 | ||
| negative pion | pi- | 150 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 150 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 438 | ||
| negative pion | pi- | 150 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 150 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 150 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 414 | ||
| negative pion | pi- | 150 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| negative pion | pi- | 150 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 150 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 437 | ||
| negative pion | pi- | 150 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 150 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 150 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 150 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 150 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 150 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| negative pion | pi- | 150 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 150 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 150 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 150 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 150 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 150 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 150 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 150 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 150 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 150 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| negative pion | pi- | 150 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 150 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 150 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 150 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 421 | ||
| negative pion | pi- | 150 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 150 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 | ||
| negative pion | pi- | 150 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 150 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| negative pion | pi- | 150 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 150 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 | ||
| negative pion | pi- | 150 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 150 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 | ||
| negative pion | pi- | 150 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| negative pion | pi- | 150 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 150 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 150 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 150 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 423 | ||
| negative pion | pi- | 150 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 418 | ||
| negative pion | pi- | 150 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 421 | ||
| negative pion | pi- | 150 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 150 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 433 | ||
| negative pion | pi- | 150 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 150 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 150 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| negative pion | pi- | 150 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 150 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 436 | ||
| negative pion | pi- | 150 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 150 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 | ||
| negative pion | pi- | 150 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 436 | ||
| negative pion | pi- | 150 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 150 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 | ||
| negative pion | pi- | 150 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 150 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 | ||
| negative pion | pi- | 150 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 150 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 150 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 423 | ||
| negative pion | pi- | 150 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 150 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 150 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 150 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 150 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 150 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 150 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 150 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 150 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 150 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 150 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 200 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 200 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 200 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 200 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 200 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 200 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 200 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 200 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 200 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 200 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 414 | ||
| negative pion | pi- | 200 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 414 | ||
| negative pion | pi- | 200 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 394 | ||
| negative pion | pi- | 200 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 200 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 200 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 200 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 200 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| negative pion | pi- | 200 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 200 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 200 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 200 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 417 | ||
| negative pion | pi- | 200 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 200 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 200 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 401 | ||
| negative pion | pi- | 200 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 200 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 200 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 200 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 200 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 200 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 200 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 386 | ||
| negative pion | pi- | 200 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 384 | ||
| negative pion | pi- | 200 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 200 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 200 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 200 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 200 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 200 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 200 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 200 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 200 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 200 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 200 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 421 | ||
| negative pion | pi- | 200 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 200 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 200 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 200 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 401 | ||
| negative pion | pi- | 200 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 200 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 200 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 200 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 200 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 200 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 200 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| negative pion | pi- | 200 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 200 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 200 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 200 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 200 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |||
| negative pion | pi- | 200 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 414 | ||
| negative pion | pi- | 200 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 200 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 200 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 414 | ||
| negative pion | pi- | 200 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 200 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 200 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 200 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 200 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 200 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 200 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 200 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 200 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 200 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 200 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 200 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 200 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 200 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 200 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 300 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 300 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 300 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 300 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 300 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 387 | ||
| negative pion | pi- | 300 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 300 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 392 | ||
| negative pion | pi- | 300 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 300 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 300 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 300 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 300 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 300 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 300 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 383 | ||
| negative pion | pi- | 300 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| negative pion | pi- | 300 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 300 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 300 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 300 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 300 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| negative pion | pi- | 300 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 395 | ||
| negative pion | pi- | 300 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 300 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 300 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| negative pion | pi- | 300 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 300 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 300 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 300 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 300 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 300 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 391 | ||
| negative pion | pi- | 300 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 391 | ||
| negative pion | pi- | 300 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 300 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 300 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 387 | ||
| negative pion | pi- | 300 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 300 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 300 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 300 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 371 | ||
| negative pion | pi- | 300 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 300 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 370 | ||
| negative pion | pi- | 300 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 300 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 300 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 300 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 390 | ||
| negative pion | pi- | 300 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 300 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 392 | ||
| negative pion | pi- | 300 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 300 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 380 | ||
| negative pion | pi- | 300 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 300 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 300 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 300 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 300 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 300 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 300 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 300 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 300 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 300 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 300 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| negative pion | pi- | 300 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 300 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| negative pion | pi- | 300 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 392 | ||
| negative pion | pi- | 300 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| negative pion | pi- | 300 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 300 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 300 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 392 | ||
| negative pion | pi- | 300 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 300 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 300 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 300 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 300 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 384 | ||
| negative pion | pi- | 300 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 300 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 401 | ||
| negative pion | pi- | 300 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 300 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| negative pion | pi- | 300 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 300 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 392 | ||
| negative pion | pi- | 300 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 300 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 300 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| negative pion | pi- | 300 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 300 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 300 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 300 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 300 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 300 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 375 | ||
| negative pion | pi- | 300 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 300 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 375 | ||
| negative pion | pi- | 300 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 300 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 400 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 400 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 400 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 400 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 391 | ||
| negative pion | pi- | 400 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 400 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 400 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 400 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 400 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 400 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 400 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 400 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| negative pion | pi- | 400 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 417 | ||
| negative pion | pi- | 400 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |||
| negative pion | pi- | 400 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 400 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 400 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 400 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| negative pion | pi- | 400 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| negative pion | pi- | 400 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 400 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 400 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 400 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 400 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 400 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 396 | ||
| negative pion | pi- | 400 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 395 | ||
| negative pion | pi- | 400 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| negative pion | pi- | 400 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| negative pion | pi- | 400 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| negative pion | pi- | 400 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| negative pion | pi- | 400 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 373 | ||
| negative pion | pi- | 400 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 400 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 371 | ||
| negative pion | pi- | 400 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 400 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 400 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 400 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 400 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 400 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 390 | ||
| negative pion | pi- | 400 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| negative pion | pi- | 400 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 416 | ||
| negative pion | pi- | 400 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 400 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 400 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 400 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 400 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 400 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 400 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 400 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 404 | ||
| negative pion | pi- | 400 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 400 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 400 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 398 | ||
| negative pion | pi- | 400 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 400 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 394 | ||
| negative pion | pi- | 400 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 400 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 400 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 400 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 400 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 400 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 400 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 400 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 400 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 400 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 403 | ||
| negative pion | pi- | 400 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 400 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 400 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 400 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 400 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 400 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 400 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 368 | ||
| negative pion | pi- | 400 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 400 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 368 | ||
| negative pion | pi- | 400 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 400 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 500 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 421 | ||
| negative pion | pi- | 500 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 500 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 418 | ||
| negative pion | pi- | 500 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 500 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| negative pion | pi- | 500 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 500 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 500 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 500 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 500 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 500 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 419 | ||
| negative pion | pi- | 500 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 500 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 500 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 417 | ||
| negative pion | pi- | 500 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 433 | ||
| negative pion | pi- | 500 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 500 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 500 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 500 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 500 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 500 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 500 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 500 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| negative pion | pi- | 500 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 500 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 500 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 500 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 500 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 500 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| negative pion | pi- | 500 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| negative pion | pi- | 500 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| negative pion | pi- | 500 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 405 | ||
| negative pion | pi- | 500 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 410 | ||
| negative pion | pi- | 500 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 383 | ||
| negative pion | pi- | 500 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 500 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 380 | ||
| negative pion | pi- | 500 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 500 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 500 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 500 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| negative pion | pi- | 500 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 500 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| negative pion | pi- | 500 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 500 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 500 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 425 | ||
| negative pion | pi- | 500 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 500 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 500 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 500 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 500 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 500 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 500 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 500 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 500 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| negative pion | pi- | 500 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 500 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| negative pion | pi- | 500 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 406 | ||
| negative pion | pi- | 500 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 | ||
| negative pion | pi- | 500 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 418 | ||
| negative pion | pi- | 500 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 432 | ||
| negative pion | pi- | 500 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 500 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| negative pion | pi- | 500 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 500 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 500 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 500 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 500 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 421 | ||
| negative pion | pi- | 500 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 417 | ||
| negative pion | pi- | 500 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 500 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 500 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 423 | ||
| negative pion | pi- | 500 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 500 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 500 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| negative pion | pi- | 500 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 500 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 500 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 378 | ||
| negative pion | pi- | 500 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 500 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 378 | ||
| negative pion | pi- | 500 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 500 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 437 | ||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 438 | ||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 436 | ||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 440 | ||
| negative pion | pi- | 600 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 600 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 437 | ||
| negative pion | pi- | 600 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 600 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| negative pion | pi- | 600 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 600 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 600 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 442 | ||
| negative pion | pi- | 600 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 442 | ||
| negative pion | pi- | 600 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 443 | ||
| negative pion | pi- | 600 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 436 | ||
| negative pion | pi- | 600 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 446 | ||
| negative pion | pi- | 600 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 442 | ||
| negative pion | pi- | 600 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 | ||
| negative pion | pi- | 600 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| negative pion | pi- | 600 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 600 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 448 | ||
| negative pion | pi- | 600 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| negative pion | pi- | 600 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| negative pion | pi- | 600 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 436 | ||
| negative pion | pi- | 600 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 | ||
| negative pion | pi- | 600 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 600 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 600 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 600 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 451 | ||
| negative pion | pi- | 600 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 442 | ||
| negative pion | pi- | 600 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 600 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 600 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 | ||
| negative pion | pi- | 600 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 425 | ||
| negative pion | pi- | 600 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 420 | ||
| negative pion | pi- | 600 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 423 | ||
| negative pion | pi- | 600 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 395 | ||
| negative pion | pi- | 600 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 391 | ||
| negative pion | pi- | 600 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 444 | ||
| negative pion | pi- | 600 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| negative pion | pi- | 600 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| negative pion | pi- | 600 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 600 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| negative pion | pi- | 600 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 600 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 600 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 600 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 600 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 445 | ||
| negative pion | pi- | 600 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 446 | ||
| negative pion | pi- | 600 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 600 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 446 | ||
| negative pion | pi- | 600 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| negative pion | pi- | 600 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 451 | ||
| negative pion | pi- | 600 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| negative pion | pi- | 600 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 440 | ||
| negative pion | pi- | 600 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| negative pion | pi- | 600 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 428 | ||
| negative pion | pi- | 600 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| negative pion | pi- | 600 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 | ||
| negative pion | pi- | 600 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 423 | ||
| negative pion | pi- | 600 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| negative pion | pi- | 600 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 437 | ||
| negative pion | pi- | 600 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| negative pion | pi- | 600 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |||
| negative pion | pi- | 600 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| negative pion | pi- | 600 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| negative pion | pi- | 600 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 446 | ||
| negative pion | pi- | 600 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 600 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| negative pion | pi- | 600 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 | ||
| negative pion | pi- | 600 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 600 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| negative pion | pi- | 600 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 600 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 | ||
| negative pion | pi- | 600 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 600 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 394 | ||
| negative pion | pi- | 600 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 600 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 394 | ||
| negative pion | pi- | 600 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 600 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 468 | ||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 469 | ||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 466 | ||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 800 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 800 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 466 | ||
| negative pion | pi- | 800 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 800 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 436 | ||
| negative pion | pi- | 800 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 800 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| negative pion | pi- | 800 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| negative pion | pi- | 800 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 800 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| negative pion | pi- | 800 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| negative pion | pi- | 800 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 800 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 800 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| negative pion | pi- | 800 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 488 | ||
| negative pion | pi- | 800 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 800 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| negative pion | pi- | 800 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| negative pion | pi- | 800 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 800 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| negative pion | pi- | 800 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| negative pion | pi- | 800 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 469 | ||
| negative pion | pi- | 800 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 487 | ||
| negative pion | pi- | 800 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| negative pion | pi- | 800 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 800 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 | ||
| negative pion | pi- | 800 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| negative pion | pi- | 800 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 451 | ||
| negative pion | pi- | 800 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 447 | ||
| negative pion | pi- | 800 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 445 | ||
| negative pion | pi- | 800 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| negative pion | pi- | 800 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 414 | ||
| negative pion | pi- | 800 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 409 | ||
| negative pion | pi- | 800 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| negative pion | pi- | 800 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| negative pion | pi- | 800 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| negative pion | pi- | 800 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 490 | ||
| negative pion | pi- | 800 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 442 | ||
| negative pion | pi- | 800 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| negative pion | pi- | 800 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| negative pion | pi- | 800 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| negative pion | pi- | 800 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |||
| negative pion | pi- | 800 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| negative pion | pi- | 800 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| negative pion | pi- | 800 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| negative pion | pi- | 800 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 800 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 800 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| negative pion | pi- | 800 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| negative pion | pi- | 800 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| negative pion | pi- | 800 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| negative pion | pi- | 800 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| negative pion | pi- | 800 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| negative pion | pi- | 800 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 466 | ||
| negative pion | pi- | 800 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| negative pion | pi- | 800 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 800 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 487 | ||
| negative pion | pi- | 800 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| negative pion | pi- | 800 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| negative pion | pi- | 800 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 800 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| negative pion | pi- | 800 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 800 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| negative pion | pi- | 800 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 800 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| negative pion | pi- | 800 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 456 | ||
| negative pion | pi- | 800 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 800 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 800 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 800 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 413 | ||
| negative pion | pi- | 800 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 800 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 489 | ||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 491 | ||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 488 | ||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| negative pion | pi- | 1000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 1000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| negative pion | pi- | 1000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 1000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 448 | ||
| negative pion | pi- | 1000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 1000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| negative pion | pi- | 1000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| negative pion | pi- | 1000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 493 | ||
| negative pion | pi- | 1000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 498 | ||
| negative pion | pi- | 1000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 487 | ||
| negative pion | pi- | 1000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 509 | ||
| negative pion | pi- | 1000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 1000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| negative pion | pi- | 1000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| negative pion | pi- | 1000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| negative pion | pi- | 1000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |||
| negative pion | pi- | 1000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 502 | ||
| negative pion | pi- | 1000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 493 | ||
| negative pion | pi- | 1000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| negative pion | pi- | 1000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| negative pion | pi- | 1000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 498 | ||
| negative pion | pi- | 1000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 1000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| negative pion | pi- | 1000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 1000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 1000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| negative pion | pi- | 1000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 467 | ||
| negative pion | pi- | 1000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| negative pion | pi- | 1000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| negative pion | pi- | 1000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| negative pion | pi- | 1000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| negative pion | pi- | 1000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| negative pion | pi- | 1000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| negative pion | pi- | 1000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| negative pion | pi- | 1000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| negative pion | pi- | 1000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| negative pion | pi- | 1000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| negative pion | pi- | 1000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 457 | ||
| negative pion | pi- | 1000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 1000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| negative pion | pi- | 1000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| negative pion | pi- | 1000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 1000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 1000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 1000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |||
| negative pion | pi- | 1000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 503 | ||
| negative pion | pi- | 1000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| negative pion | pi- | 1000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| negative pion | pi- | 1000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 1000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 1000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| negative pion | pi- | 1000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| negative pion | pi- | 1000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 1000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| negative pion | pi- | 1000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| negative pion | pi- | 1000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| negative pion | pi- | 1000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| negative pion | pi- | 1000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 501 | ||
| negative pion | pi- | 1000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| negative pion | pi- | 1000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| negative pion | pi- | 1000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| negative pion | pi- | 1000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| negative pion | pi- | 1000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 1000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| negative pion | pi- | 1000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 1000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 1000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| negative pion | pi- | 1000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 527 | ||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 525 | ||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| negative pion | pi- | 1500 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 1500 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 1500 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 1500 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 1500 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 1500 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 1500 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| negative pion | pi- | 1500 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 | ||
| negative pion | pi- | 1500 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| negative pion | pi- | 1500 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 1500 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| negative pion | pi- | 1500 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 1500 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| negative pion | pi- | 1500 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 1500 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 560 | ||
| negative pion | pi- | 1500 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| negative pion | pi- | 1500 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| negative pion | pi- | 1500 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| negative pion | pi- | 1500 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| negative pion | pi- | 1500 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| negative pion | pi- | 1500 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 1500 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 556 | ||
| negative pion | pi- | 1500 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| negative pion | pi- | 1500 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 1500 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 503 | ||
| negative pion | pi- | 1500 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 501 | ||
| negative pion | pi- | 1500 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| negative pion | pi- | 1500 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 490 | ||
| negative pion | pi- | 1500 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| negative pion | pi- | 1500 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 498 | ||
| negative pion | pi- | 1500 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 | ||
| negative pion | pi- | 1500 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 446 | ||
| negative pion | pi- | 1500 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| negative pion | pi- | 1500 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| negative pion | pi- | 1500 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| negative pion | pi- | 1500 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| negative pion | pi- | 1500 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| negative pion | pi- | 1500 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 1500 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 1500 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 1500 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 1500 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| negative pion | pi- | 1500 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 1500 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| negative pion | pi- | 1500 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| negative pion | pi- | 1500 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| negative pion | pi- | 1500 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| negative pion | pi- | 1500 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| negative pion | pi- | 1500 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| negative pion | pi- | 1500 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 508 | ||
| negative pion | pi- | 1500 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| negative pion | pi- | 1500 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 502 | ||
| negative pion | pi- | 1500 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 1500 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 1500 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 1500 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 1500 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 1500 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| negative pion | pi- | 1500 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| negative pion | pi- | 1500 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| negative pion | pi- | 1500 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 1500 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 1500 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| negative pion | pi- | 1500 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 1500 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| negative pion | pi- | 1500 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 1500 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 508 | ||
| negative pion | pi- | 1500 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 454 | ||
| negative pion | pi- | 1500 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 1500 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 454 | ||
| negative pion | pi- | 1500 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 1500 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 547 | ||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 550 | ||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 556 | ||
| negative pion | pi- | 2000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 2000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 2000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| negative pion | pi- | 2000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 2000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 2000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 503 | ||
| negative pion | pi- | 2000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 2000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 2000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 2000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 2000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 560 | ||
| negative pion | pi- | 2000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| negative pion | pi- | 2000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| negative pion | pi- | 2000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 2000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 570 | ||
| negative pion | pi- | 2000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 2000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| negative pion | pi- | 2000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| negative pion | pi- | 2000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 2000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 2000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| negative pion | pi- | 2000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| negative pion | pi- | 2000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 | ||
| negative pion | pi- | 2000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 2000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 2000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| negative pion | pi- | 2000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 2000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 2000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 539 | ||
| negative pion | pi- | 2000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 2000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| negative pion | pi- | 2000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 2000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| negative pion | pi- | 2000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 2000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 2000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| negative pion | pi- | 2000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 2000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 2000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 2000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| negative pion | pi- | 2000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 2000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| negative pion | pi- | 2000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| negative pion | pi- | 2000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| negative pion | pi- | 2000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| negative pion | pi- | 2000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| negative pion | pi- | 2000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 2000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 579 | ||
| negative pion | pi- | 2000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 2000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 509 | ||
| negative pion | pi- | 2000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 2000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| negative pion | pi- | 2000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 568 | ||
| negative pion | pi- | 2000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 2000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 2000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| negative pion | pi- | 2000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 2000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 2000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 2000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 2000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| negative pion | pi- | 2000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 565 | ||
| negative pion | pi- | 2000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| negative pion | pi- | 2000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| negative pion | pi- | 2000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| negative pion | pi- | 2000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| negative pion | pi- | 2000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 2000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 515 | ||
| negative pion | pi- | 2000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 592 | ||
| negative pion | pi- | 2000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| negative pion | pi- | 2000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| negative pion | pi- | 2000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 2000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 2000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 578 | ||
| negative pion | pi- | 2000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 2000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 2000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 2000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| negative pion | pi- | 2000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 2000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| negative pion | pi- | 2000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 2000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 2000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| negative pion | pi- | 2000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 2000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| negative pion | pi- | 2000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 2000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 555 | ||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 560 | ||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 550 | ||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 568 | ||
| negative pion | pi- | 3000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 3000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| negative pion | pi- | 3000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 3000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 3000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 3000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 502 | ||
| negative pion | pi- | 3000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| negative pion | pi- | 3000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 3000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 3000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| negative pion | pi- | 3000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 583 | ||
| negative pion | pi- | 3000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| negative pion | pi- | 3000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 3000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 3000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| negative pion | pi- | 3000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| negative pion | pi- | 3000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| negative pion | pi- | 3000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| negative pion | pi- | 3000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 3000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| negative pion | pi- | 3000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| negative pion | pi- | 3000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 602 | ||
| negative pion | pi- | 3000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 3000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 3000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| negative pion | pi- | 3000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 3000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 3000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| negative pion | pi- | 3000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| negative pion | pi- | 3000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| negative pion | pi- | 3000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 3000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 3000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| negative pion | pi- | 3000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 3000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 3000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 3000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| negative pion | pi- | 3000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 594 | ||
| negative pion | pi- | 3000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| negative pion | pi- | 3000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| negative pion | pi- | 3000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| negative pion | pi- | 3000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 591 | ||
| negative pion | pi- | 3000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| negative pion | pi- | 3000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| negative pion | pi- | 3000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 551 | ||
| negative pion | pi- | 3000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| negative pion | pi- | 3000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| negative pion | pi- | 3000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 3000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| negative pion | pi- | 3000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| negative pion | pi- | 3000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| negative pion | pi- | 3000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 3000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 517 | ||
| negative pion | pi- | 3000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 3000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| negative pion | pi- | 3000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| negative pion | pi- | 3000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| negative pion | pi- | 3000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 3000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| negative pion | pi- | 3000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 588 | ||
| negative pion | pi- | 3000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| negative pion | pi- | 3000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| negative pion | pi- | 3000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| negative pion | pi- | 3000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 3000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| negative pion | pi- | 3000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 3000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| negative pion | pi- | 3000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 3000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 3000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 3000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 3000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 3000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| negative pion | pi- | 3000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 3000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 572 | ||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 578 | ||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| negative pion | pi- | 4000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 4000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| negative pion | pi- | 4000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 4000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| negative pion | pi- | 4000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 515 | ||
| negative pion | pi- | 4000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 4000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 588 | ||
| negative pion | pi- | 4000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 583 | ||
| negative pion | pi- | 4000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 560 | ||
| negative pion | pi- | 4000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 4000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 578 | ||
| negative pion | pi- | 4000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| negative pion | pi- | 4000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 615 | ||
| negative pion | pi- | 4000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| negative pion | pi- | 4000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| negative pion | pi- | 4000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 4000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| negative pion | pi- | 4000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| negative pion | pi- | 4000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| negative pion | pi- | 4000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 623 | ||
| negative pion | pi- | 4000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 4000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| negative pion | pi- | 4000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| negative pion | pi- | 4000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| negative pion | pi- | 4000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| negative pion | pi- | 4000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| negative pion | pi- | 4000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| negative pion | pi- | 4000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| negative pion | pi- | 4000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| negative pion | pi- | 4000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| negative pion | pi- | 4000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 4000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 614 | ||
| negative pion | pi- | 4000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 4000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| negative pion | pi- | 4000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 4000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 4000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| negative pion | pi- | 4000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 4000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| negative pion | pi- | 4000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 4000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| negative pion | pi- | 4000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| negative pion | pi- | 4000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| negative pion | pi- | 4000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| negative pion | pi- | 4000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 4000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 4000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 551 | ||
| negative pion | pi- | 4000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| negative pion | pi- | 4000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| negative pion | pi- | 4000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| negative pion | pi- | 4000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| negative pion | pi- | 4000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| negative pion | pi- | 4000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 624 | ||
| negative pion | pi- | 4000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| negative pion | pi- | 4000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| negative pion | pi- | 4000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 597 | ||
| negative pion | pi- | 4000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| negative pion | pi- | 4000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| negative pion | pi- | 4000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 556 | ||
| negative pion | pi- | 4000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 4000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 4000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| negative pion | pi- | 4000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 4000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 4000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 4000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| negative pion | pi- | 4000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 4000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 601 | ||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 607 | ||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 594 | ||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| negative pion | pi- | 5000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 5000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 5000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 5000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| negative pion | pi- | 5000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 5000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| negative pion | pi- | 5000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 634 | ||
| negative pion | pi- | 5000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| negative pion | pi- | 5000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 610 | ||
| negative pion | pi- | 5000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 5000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| negative pion | pi- | 5000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 607 | ||
| negative pion | pi- | 5000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 597 | ||
| negative pion | pi- | 5000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 646 | ||
| negative pion | pi- | 5000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 638 | ||
| negative pion | pi- | 5000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| negative pion | pi- | 5000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| negative pion | pi- | 5000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| negative pion | pi- | 5000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| negative pion | pi- | 5000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| negative pion | pi- | 5000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 659 | ||
| negative pion | pi- | 5000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 617 | ||
| negative pion | pi- | 5000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| negative pion | pi- | 5000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| negative pion | pi- | 5000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| negative pion | pi- | 5000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| negative pion | pi- | 5000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| negative pion | pi- | 5000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| negative pion | pi- | 5000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| negative pion | pi- | 5000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 493 | ||
| negative pion | pi- | 5000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 620 | ||
| negative pion | pi- | 5000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 5000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 646 | ||
| negative pion | pi- | 5000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 5000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 631 | ||
| negative pion | pi- | 5000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 5000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 539 | ||
| negative pion | pi- | 5000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| negative pion | pi- | 5000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 658 | ||
| negative pion | pi- | 5000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 624 | ||
| negative pion | pi- | 5000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 622 | ||
| negative pion | pi- | 5000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| negative pion | pi- | 5000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 649 | ||
| negative pion | pi- | 5000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 626 | ||
| negative pion | pi- | 5000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| negative pion | pi- | 5000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 5000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 5000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 5000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| negative pion | pi- | 5000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 5000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 | ||
| negative pion | pi- | 5000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| negative pion | pi- | 5000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 667 | ||
| negative pion | pi- | 5000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| negative pion | pi- | 5000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 5000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 662 | ||
| negative pion | pi- | 5000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 643 | ||
| negative pion | pi- | 5000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 647 | ||
| negative pion | pi- | 5000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| negative pion | pi- | 5000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| negative pion | pi- | 5000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 5000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| negative pion | pi- | 5000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 5000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 581 | ||
| negative pion | pi- | 5000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| negative pion | pi- | 5000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 5000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 5000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| negative pion | pi- | 5000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 5000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 631 | ||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 638 | ||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 624 | ||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 654 | ||
| negative pion | pi- | 6000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 6000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| negative pion | pi- | 6000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 6000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| negative pion | pi- | 6000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 6000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| negative pion | pi- | 6000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 669 | ||
| negative pion | pi- | 6000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 651 | ||
| negative pion | pi- | 6000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 640 | ||
| negative pion | pi- | 6000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 614 | ||
| negative pion | pi- | 6000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 664 | ||
| negative pion | pi- | 6000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| negative pion | pi- | 6000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 624 | ||
| negative pion | pi- | 6000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 679 | ||
| negative pion | pi- | 6000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 6000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 672 | ||
| negative pion | pi- | 6000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| negative pion | pi- | 6000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 662 | ||
| negative pion | pi- | 6000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| negative pion | pi- | 6000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| negative pion | pi- | 6000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| negative pion | pi- | 6000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 697 | ||
| negative pion | pi- | 6000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 651 | ||
| negative pion | pi- | 6000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| negative pion | pi- | 6000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| negative pion | pi- | 6000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| negative pion | pi- | 6000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| negative pion | pi- | 6000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 565 | ||
| negative pion | pi- | 6000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| negative pion | pi- | 6000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| negative pion | pi- | 6000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| negative pion | pi- | 6000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 653 | ||
| negative pion | pi- | 6000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 631 | ||
| negative pion | pi- | 6000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 681 | ||
| negative pion | pi- | 6000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 667 | ||
| negative pion | pi- | 6000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| negative pion | pi- | 6000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| negative pion | pi- | 6000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 6000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 696 | ||
| negative pion | pi- | 6000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 6000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 662 | ||
| negative pion | pi- | 6000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 655 | ||
| negative pion | pi- | 6000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 627 | ||
| negative pion | pi- | 6000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 686 | ||
| negative pion | pi- | 6000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 661 | ||
| negative pion | pi- | 6000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 650 | ||
| negative pion | pi- | 6000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| negative pion | pi- | 6000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| negative pion | pi- | 6000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| negative pion | pi- | 6000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| negative pion | pi- | 6000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 578 | ||
| negative pion | pi- | 6000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 706 | ||
| negative pion | pi- | 6000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| negative pion | pi- | 6000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 6000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 699 | ||
| negative pion | pi- | 6000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 680 | ||
| negative pion | pi- | 6000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 684 | ||
| negative pion | pi- | 6000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 663 | ||
| negative pion | pi- | 6000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 661 | ||
| negative pion | pi- | 6000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 6000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 635 | ||
| negative pion | pi- | 6000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 6000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| negative pion | pi- | 6000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| negative pion | pi- | 6000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 6000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| negative pion | pi- | 6000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 6000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| negative pion | pi- | 6000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 6000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 680 | ||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 689 | ||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 671 | ||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 708 | ||
| negative pion | pi- | 8000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 8000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 677 | ||
| negative pion | pi- | 8000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 8000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 602 | ||
| negative pion | pi- | 8000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 8000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 595 | ||
| negative pion | pi- | 8000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 721 | ||
| negative pion | pi- | 8000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 704 | ||
| negative pion | pi- | 8000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 689 | ||
| negative pion | pi- | 8000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 658 | ||
| negative pion | pi- | 8000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 727 | ||
| negative pion | pi- | 8000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 689 | ||
| negative pion | pi- | 8000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 664 | ||
| negative pion | pi- | 8000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 726 | ||
| negative pion | pi- | 8000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 727 | ||
| negative pion | pi- | 8000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 693 | ||
| negative pion | pi- | 8000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 714 | ||
| negative pion | pi- | 8000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 674 | ||
| negative pion | pi- | 8000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 644 | ||
| negative pion | pi- | 8000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 649 | ||
| negative pion | pi- | 8000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 755 | ||
| negative pion | pi- | 8000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 712 | ||
| negative pion | pi- | 8000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 635 | ||
| negative pion | pi- | 8000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| negative pion | pi- | 8000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| negative pion | pi- | 8000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| negative pion | pi- | 8000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| negative pion | pi- | 8000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| negative pion | pi- | 8000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| negative pion | pi- | 8000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| negative pion | pi- | 8000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 707 | ||
| negative pion | pi- | 8000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 | ||
| negative pion | pi- | 8000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| negative pion | pi- | 8000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 8000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 740 | ||
| negative pion | pi- | 8000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 8000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| negative pion | pi- | 8000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 8000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 610 | ||
| negative pion | pi- | 8000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 8000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 757 | ||
| negative pion | pi- | 8000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 729 | ||
| negative pion | pi- | 8000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 711 | ||
| negative pion | pi- | 8000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 674 | ||
| negative pion | pi- | 8000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| negative pion | pi- | 8000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 722 | ||
| negative pion | pi- | 8000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 700 | ||
| negative pion | pi- | 8000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 675 | ||
| negative pion | pi- | 8000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 648 | ||
| negative pion | pi- | 8000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 639 | ||
| negative pion | pi- | 8000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| negative pion | pi- | 8000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 616 | ||
| negative pion | pi- | 8000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 765 | ||
| negative pion | pi- | 8000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 677 | ||
| negative pion | pi- | 8000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 754 | ||
| negative pion | pi- | 8000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 740 | ||
| negative pion | pi- | 8000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 743 | ||
| negative pion | pi- | 8000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 718 | ||
| negative pion | pi- | 8000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 718 | ||
| negative pion | pi- | 8000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 8000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 8000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 680 | ||
| negative pion | pi- | 8000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 8000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 675 | ||
| negative pion | pi- | 8000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 644 | ||
| negative pion | pi- | 8000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| negative pion | pi- | 8000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 8000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| negative pion | pi- | 8000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 8000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 714 | ||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 725 | ||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 703 | ||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 746 | ||
| negative pion | pi- | 10000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 10000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 709 | ||
| negative pion | pi- | 10000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 10000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 631 | ||
| negative pion | pi- | 10000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 10000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 619 | ||
| negative pion | pi- | 10000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 757 | ||
| negative pion | pi- | 10000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 740 | ||
| negative pion | pi- | 10000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 723 | ||
| negative pion | pi- | 10000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 686 | ||
| negative pion | pi- | 10000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 769 | ||
| negative pion | pi- | 10000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 723 | ||
| negative pion | pi- | 10000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 701 | ||
| negative pion | pi- | 10000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 755 | ||
| negative pion | pi- | 10000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 10000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 764 | ||
| negative pion | pi- | 10000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 729 | ||
| negative pion | pi- | 10000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 753 | ||
| negative pion | pi- | 10000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 706 | ||
| negative pion | pi- | 10000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 669 | ||
| negative pion | pi- | 10000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 684 | ||
| negative pion | pi- | 10000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 796 | ||
| negative pion | pi- | 10000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 753 | ||
| negative pion | pi- | 10000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 664 | ||
| negative pion | pi- | 10000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 647 | ||
| negative pion | pi- | 10000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 623 | ||
| negative pion | pi- | 10000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 609 | ||
| negative pion | pi- | 10000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| negative pion | pi- | 10000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 624 | ||
| negative pion | pi- | 10000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 579 | ||
| negative pion | pi- | 10000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 | ||
| negative pion | pi- | 10000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 743 | ||
| negative pion | pi- | 10000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 716 | ||
| negative pion | pi- | 10000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 803 | ||
| negative pion | pi- | 10000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 10000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 | ||
| negative pion | pi- | 10000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| negative pion | pi- | 10000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 610 | ||
| negative pion | pi- | 10000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 642 | ||
| negative pion | pi- | 10000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 10000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 798 | ||
| negative pion | pi- | 10000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 768 | ||
| negative pion | pi- | 10000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 749 | ||
| negative pion | pi- | 10000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 705 | ||
| negative pion | pi- | 10000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 795 | ||
| negative pion | pi- | 10000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 766 | ||
| negative pion | pi- | 10000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 735 | ||
| negative pion | pi- | 10000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 708 | ||
| negative pion | pi- | 10000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 678 | ||
| negative pion | pi- | 10000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 667 | ||
| negative pion | pi- | 10000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 651 | ||
| negative pion | pi- | 10000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 10000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 633 | ||
| negative pion | pi- | 10000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 10000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 10000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 804 | ||
| negative pion | pi- | 10000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 709 | ||
| negative pion | pi- | 10000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 | ||
| negative pion | pi- | 10000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 779 | ||
| negative pion | pi- | 10000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 783 | ||
| negative pion | pi- | 10000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 756 | ||
| negative pion | pi- | 10000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 758 | ||
| negative pion | pi- | 10000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 10000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 709 | ||
| negative pion | pi- | 10000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 708 | ||
| negative pion | pi- | 10000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 10000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 673 | ||
| negative pion | pi- | 10000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 10000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| negative pion | pi- | 10000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 10000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| negative pion | pi- | 10000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 10000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 772 | ||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 787 | ||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 757 | ||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 812 | ||
| negative pion | pi- | 15000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 15000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 767 | ||
| negative pion | pi- | 15000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 15000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 675 | ||
| negative pion | pi- | 15000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 15000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 660 | ||
| negative pion | pi- | 15000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 826 | ||
| negative pion | pi- | 15000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 800 | ||
| negative pion | pi- | 15000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 782 | ||
| negative pion | pi- | 15000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 734 | ||
| negative pion | pi- | 15000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 839 | ||
| negative pion | pi- | 15000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 15000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 781 | ||
| negative pion | pi- | 15000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 758 | ||
| negative pion | pi- | 15000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 15000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 841 | ||
| negative pion | pi- | 15000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 15000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 828 | ||
| negative pion | pi- | 15000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 15000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 782 | ||
| negative pion | pi- | 15000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 824 | ||
| negative pion | pi- | 15000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| negative pion | pi- | 15000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 754 | ||
| negative pion | pi- | 15000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 714 | ||
| negative pion | pi- | 15000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 871 | ||
| negative pion | pi- | 15000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 15000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 813 | ||
| negative pion | pi- | 15000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 15000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 715 | ||
| negative pion | pi- | 15000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 696 | ||
| negative pion | pi- | 15000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 665 | ||
| negative pion | pi- | 15000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 650 | ||
| negative pion | pi- | 15000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 673 | ||
| negative pion | pi- | 15000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 668 | ||
| negative pion | pi- | 15000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 620 | ||
| negative pion | pi- | 15000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| negative pion | pi- | 15000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 807 | ||
| negative pion | pi- | 15000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 771 | ||
| negative pion | pi- | 15000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 863 | ||
| negative pion | pi- | 15000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 15000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 15000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 833 | ||
| negative pion | pi- | 15000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 15000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 15000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 668 | ||
| negative pion | pi- | 15000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 699 | ||
| negative pion | pi- | 15000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 15000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 15000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 870 | ||
| negative pion | pi- | 15000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 824 | ||
| negative pion | pi- | 15000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 15000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 821 | ||
| negative pion | pi- | 15000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 755 | ||
| negative pion | pi- | 15000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 857 | ||
| negative pion | pi- | 15000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 15000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 817 | ||
| negative pion | pi- | 15000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 15000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 802 | ||
| negative pion | pi- | 15000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 773 | ||
| negative pion | pi- | 15000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 733 | ||
| negative pion | pi- | 15000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 717 | ||
| negative pion | pi- | 15000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 697 | ||
| negative pion | pi- | 15000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 671 | ||
| negative pion | pi- | 15000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 879 | ||
| negative pion | pi- | 15000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 767 | ||
| negative pion | pi- | 15000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 862 | ||
| negative pion | pi- | 15000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 855 | ||
| negative pion | pi- | 15000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 855 | ||
| negative pion | pi- | 15000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 819 | ||
| negative pion | pi- | 15000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| negative pion | pi- | 15000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 15000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 770 | ||
| negative pion | pi- | 15000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 766 | ||
| negative pion | pi- | 15000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 15000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 15000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 718 | ||
| negative pion | pi- | 15000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| negative pion | pi- | 15000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 15000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| negative pion | pi- | 15000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 15000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 820 | ||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 837 | ||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 803 | ||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 865 | ||
| negative pion | pi- | 20000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 20000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 813 | ||
| negative pion | pi- | 20000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 20000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 715 | ||
| negative pion | pi- | 20000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 20000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 695 | ||
| negative pion | pi- | 20000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 20000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 879 | ||
| negative pion | pi- | 20000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 849 | ||
| negative pion | pi- | 20000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 829 | ||
| negative pion | pi- | 20000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 776 | ||
| negative pion | pi- | 20000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 897 | ||
| negative pion | pi- | 20000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 835 | ||
| negative pion | pi- | 20000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 789 | ||
| negative pion | pi- | 20000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 915 | ||
| negative pion | pi- | 20000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 880 | ||
| negative pion | pi- | 20000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 826 | ||
| negative pion | pi- | 20000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 868 | ||
| negative pion | pi- | 20000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 20000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 788 | ||
| negative pion | pi- | 20000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 20000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 821 | ||
| negative pion | pi- | 20000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 741 | ||
| negative pion | pi- | 20000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 939 | ||
| negative pion | pi- | 20000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 855 | ||
| negative pion | pi- | 20000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 755 | ||
| negative pion | pi- | 20000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 735 | ||
| negative pion | pi- | 20000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 698 | ||
| negative pion | pi- | 20000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 | ||
| negative pion | pi- | 20000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 703 | ||
| negative pion | pi- | 20000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 694 | ||
| negative pion | pi- | 20000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 653 | ||
| negative pion | pi- | 20000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| negative pion | pi- | 20000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 859 | ||
| negative pion | pi- | 20000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 812 | ||
| negative pion | pi- | 20000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 918 | ||
| negative pion | pi- | 20000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 20000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 870 | ||
| negative pion | pi- | 20000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| negative pion | pi- | 20000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 720 | ||
| negative pion | pi- | 20000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 20000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 712 | ||
| negative pion | pi- | 20000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 20000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 20000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 910 | ||
| negative pion | pi- | 20000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 20000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 874 | ||
| negative pion | pi- | 20000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 20000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 20000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 878 | ||
| negative pion | pi- | 20000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 795 | ||
| negative pion | pi- | 20000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 20000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 904 | ||
| negative pion | pi- | 20000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 868 | ||
| negative pion | pi- | 20000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 855 | ||
| negative pion | pi- | 20000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 815 | ||
| negative pion | pi- | 20000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 776 | ||
| negative pion | pi- | 20000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 757 | ||
| negative pion | pi- | 20000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 738 | ||
| negative pion | pi- | 20000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 704 | ||
| negative pion | pi- | 20000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 943 | ||
| negative pion | pi- | 20000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 813 | ||
| negative pion | pi- | 20000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 908 | ||
| negative pion | pi- | 20000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 20000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 20000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 917 | ||
| negative pion | pi- | 20000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 906 | ||
| negative pion | pi- | 20000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 868 | ||
| negative pion | pi- | 20000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 880 | ||
| negative pion | pi- | 20000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 822 | ||
| negative pion | pi- | 20000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 20000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 834 | ||
| negative pion | pi- | 20000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 20000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 20000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 739 | ||
| negative pion | pi- | 20000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 639 | ||
| negative pion | pi- | 20000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 20000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 639 | ||
| negative pion | pi- | 20000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 20000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 893 | ||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 911 | ||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 875 | ||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 948 | ||
| negative pion | pi- | 30000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 30000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 890 | ||
| negative pion | pi- | 30000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 30000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 769 | ||
| negative pion | pi- | 30000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 30000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| negative pion | pi- | 30000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 969 | ||
| negative pion | pi- | 30000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 940 | ||
| negative pion | pi- | 30000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 897 | ||
| negative pion | pi- | 30000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 838 | ||
| negative pion | pi- | 30000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 966 | ||
| negative pion | pi- | 30000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 915 | ||
| negative pion | pi- | 30000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 30000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 877 | ||
| negative pion | pi- | 30000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 30000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 963 | ||
| negative pion | pi- | 30000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 899 | ||
| negative pion | pi- | 30000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 30000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 928 | ||
| negative pion | pi- | 30000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 30000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 858 | ||
| negative pion | pi- | 30000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 30000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 877 | ||
| negative pion | pi- | 30000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 796 | ||
| negative pion | pi- | 30000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 30000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 933 | ||
| negative pion | pi- | 30000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| negative pion | pi- | 30000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 798 | ||
| negative pion | pi- | 30000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 758 | ||
| negative pion | pi- | 30000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 732 | ||
| negative pion | pi- | 30000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 761 | ||
| negative pion | pi- | 30000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 744 | ||
| negative pion | pi- | 30000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 706 | ||
| negative pion | pi- | 30000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 30000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 674 | ||
| negative pion | pi- | 30000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 30000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 937 | ||
| negative pion | pi- | 30000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 883 | ||
| negative pion | pi- | 30000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 30000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 30000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 949 | ||
| negative pion | pi- | 30000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 30000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 768 | ||
| negative pion | pi- | 30000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 759 | ||
| negative pion | pi- | 30000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 977 | ||
| negative pion | pi- | 30000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 30000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 943 | ||
| negative pion | pi- | 30000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 948 | ||
| negative pion | pi- | 30000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 876 | ||
| negative pion | pi- | 30000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 30000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 997 | ||
| negative pion | pi- | 30000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 960 | ||
| negative pion | pi- | 30000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 935 | ||
| negative pion | pi- | 30000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 883 | ||
| negative pion | pi- | 30000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 848 | ||
| negative pion | pi- | 30000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 824 | ||
| negative pion | pi- | 30000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 812 | ||
| negative pion | pi- | 30000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 761 | ||
| negative pion | pi- | 30000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 30000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 30000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 890 | ||
| negative pion | pi- | 30000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 997 | ||
| negative pion | pi- | 30000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 995 | ||
| negative pion | pi- | 30000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 994 | ||
| negative pion | pi- | 30000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 954 | ||
| negative pion | pi- | 30000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 958 | ||
| negative pion | pi- | 30000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 898 | ||
| negative pion | pi- | 30000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 30000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 891 | ||
| negative pion | pi- | 30000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 30000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 30000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 787 | ||
| negative pion | pi- | 30000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 30000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 683 | ||
| negative pion | pi- | 30000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 30000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 683 | ||
| negative pion | pi- | 30000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 30000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 955 | ||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 980 | ||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 931 | ||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 40000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 40000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 950 | ||
| negative pion | pi- | 40000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 40000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 821 | ||
| negative pion | pi- | 40000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 40000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 796 | ||
| negative pion | pi- | 40000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| negative pion | pi- | 40000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 40000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 957 | ||
| negative pion | pi- | 40000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 883 | ||
| negative pion | pi- | 40000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 40000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 977 | ||
| negative pion | pi- | 40000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 40000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 963 | ||
| negative pion | pi- | 40000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 40000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 40000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 960 | ||
| negative pion | pi- | 40000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 40000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 996 | ||
| negative pion | pi- | 40000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 920 | ||
| negative pion | pi- | 40000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 920 | ||
| negative pion | pi- | 40000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 842 | ||
| negative pion | pi- | 40000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 40000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 40000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 878 | ||
| negative pion | pi- | 40000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 845 | ||
| negative pion | pi- | 40000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 808 | ||
| negative pion | pi- | 40000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 764 | ||
| negative pion | pi- | 40000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 808 | ||
| negative pion | pi- | 40000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 791 | ||
| negative pion | pi- | 40000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| negative pion | pi- | 40000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 711 | ||
| negative pion | pi- | 40000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 40000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 941 | ||
| negative pion | pi- | 40000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 40000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 40000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 40000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 40000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 802 | ||
| negative pion | pi- | 40000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 801 | ||
| negative pion | pi- | 40000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 40000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 40000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 40000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 930 | ||
| negative pion | pi- | 40000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 40000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 40000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 40000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 40000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 937 | ||
| negative pion | pi- | 40000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 907 | ||
| negative pion | pi- | 40000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 876 | ||
| negative pion | pi- | 40000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 856 | ||
| negative pion | pi- | 40000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 803 | ||
| negative pion | pi- | 40000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 40000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 40000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 950 | ||
| negative pion | pi- | 40000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 40000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 40000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 40000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 40000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 40000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 956 | ||
| negative pion | pi- | 40000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 932 | ||
| negative pion | pi- | 40000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 40000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 40000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 845 | ||
| negative pion | pi- | 40000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 40000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 40000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 712 | ||
| negative pion | pi- | 40000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 40000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 712 | ||
| negative pion | pi- | 40000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 40000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 981 | ||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 50000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 50000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 50000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 50000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 866 | ||
| negative pion | pi- | 50000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 50000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 837 | ||
| negative pion | pi- | 50000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 50000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 50000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 50000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 50000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 924 | ||
| negative pion | pi- | 50000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 50000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 50000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 50000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 50000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 50000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 50000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 50000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 50000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 50000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 50000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 973 | ||
| negative pion | pi- | 50000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 50000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 965 | ||
| negative pion | pi- | 50000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 891 | ||
| negative pion | pi- | 50000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 50000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 50000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 50000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 924 | ||
| negative pion | pi- | 50000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 887 | ||
| negative pion | pi- | 50000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 848 | ||
| negative pion | pi- | 50000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 793 | ||
| negative pion | pi- | 50000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 846 | ||
| negative pion | pi- | 50000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 832 | ||
| negative pion | pi- | 50000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 788 | ||
| negative pion | pi- | 50000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 744 | ||
| negative pion | pi- | 50000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 50000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 993 | ||
| negative pion | pi- | 50000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 50000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 50000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 830 | ||
| negative pion | pi- | 50000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 50000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 835 | ||
| negative pion | pi- | 50000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| negative pion | pi- | 50000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 50000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 50000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 50000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 974 | ||
| negative pion | pi- | 50000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 50000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| negative pion | pi- | 50000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 50000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 50000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 986 | ||
| negative pion | pi- | 50000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 957 | ||
| negative pion | pi- | 50000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 920 | ||
| negative pion | pi- | 50000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 885 | ||
| negative pion | pi- | 50000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 839 | ||
| negative pion | pi- | 50000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 50000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 50000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| negative pion | pi- | 50000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 50000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 50000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| negative pion | pi- | 50000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 50000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| negative pion | pi- | 50000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 50000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 980 | ||
| negative pion | pi- | 50000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 899 | ||
| negative pion | pi- | 50000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 50000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 50000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 743 | ||
| negative pion | pi- | 50000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 50000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 743 | ||
| negative pion | pi- | 50000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 50000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1090 | ||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 60000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 60000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| negative pion | pi- | 60000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 60000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 901 | ||
| negative pion | pi- | 60000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 60000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 874 | ||
| negative pion | pi- | 60000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 60000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1170 | ||
| negative pion | pi- | 60000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 60000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 60000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 965 | ||
| negative pion | pi- | 60000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 60000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 60000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 60000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 60000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 60000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| negative pion | pi- | 60000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 60000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 60000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 60000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 60000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 60000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 940 | ||
| negative pion | pi- | 60000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 60000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 60000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 966 | ||
| negative pion | pi- | 60000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 926 | ||
| negative pion | pi- | 60000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 879 | ||
| negative pion | pi- | 60000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 822 | ||
| negative pion | pi- | 60000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 878 | ||
| negative pion | pi- | 60000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 866 | ||
| negative pion | pi- | 60000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 821 | ||
| negative pion | pi- | 60000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 60000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 773 | ||
| negative pion | pi- | 60000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 60000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 60000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 60000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 60000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 60000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 857 | ||
| negative pion | pi- | 60000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 866 | ||
| negative pion | pi- | 60000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 60000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 60000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 60000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 60000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 60000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 60000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 60000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 60000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 60000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 60000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 60000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 962 | ||
| negative pion | pi- | 60000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 910 | ||
| negative pion | pi- | 60000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 60000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 875 | ||
| negative pion | pi- | 60000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 60000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 60000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| negative pion | pi- | 60000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 60000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 60000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 60000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| negative pion | pi- | 60000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 60000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 60000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 60000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 60000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| negative pion | pi- | 60000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 60000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 946 | ||
| negative pion | pi- | 60000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 60000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 60000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 764 | ||
| negative pion | pi- | 60000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 60000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 764 | ||
| negative pion | pi- | 60000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 60000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1180 | ||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| negative pion | pi- | 80000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 80000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 80000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 80000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 969 | ||
| negative pion | pi- | 80000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 942 | ||
| negative pion | pi- | 80000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 80000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 80000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 80000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| negative pion | pi- | 80000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 80000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| negative pion | pi- | 80000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| negative pion | pi- | 80000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| negative pion | pi- | 80000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 80000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| negative pion | pi- | 80000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 80000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| negative pion | pi- | 80000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 80000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| negative pion | pi- | 80000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| negative pion | pi- | 80000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| negative pion | pi- | 80000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| negative pion | pi- | 80000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 80000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 80000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 80000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 935 | ||
| negative pion | pi- | 80000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 884 | ||
| negative pion | pi- | 80000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 941 | ||
| negative pion | pi- | 80000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 908 | ||
| negative pion | pi- | 80000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 883 | ||
| negative pion | pi- | 80000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 828 | ||
| negative pion | pi- | 80000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| negative pion | pi- | 80000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 80000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| negative pion | pi- | 80000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| negative pion | pi- | 80000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 919 | ||
| negative pion | pi- | 80000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 930 | ||
| negative pion | pi- | 80000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1280 | ||
| negative pion | pi- | 80000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1280 | ||
| negative pion | pi- | 80000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| negative pion | pi- | 80000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 80000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 80000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| negative pion | pi- | 80000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 | ||
| negative pion | pi- | 80000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| negative pion | pi- | 80000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 80000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| negative pion | pi- | 80000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| negative pion | pi- | 80000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 976 | ||
| negative pion | pi- | 80000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 941 | ||
| negative pion | pi- | 80000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1360 | ||
| negative pion | pi- | 80000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 80000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 80000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1400 | ||
| negative pion | pi- | 80000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1310 | ||
| negative pion | pi- | 80000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| negative pion | pi- | 80000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| negative pion | pi- | 80000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 | ||
| negative pion | pi- | 80000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 80000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| negative pion | pi- | 80000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 80000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 80000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 80000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 80000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 802 | ||
| negative pion | pi- | 80000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 80000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 802 | ||
| negative pion | pi- | 80000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 80000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1230 | ||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1190 | ||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| negative pion | pi- | 100000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 100000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 100000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| negative pion | pi- | 100000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| negative pion | pi- | 100000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 100000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 100000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1350 | ||
| negative pion | pi- | 100000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1280 | ||
| negative pion | pi- | 100000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 | ||
| negative pion | pi- | 100000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 100000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1360 | ||
| negative pion | pi- | 100000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| negative pion | pi- | 100000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 100000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1430 | ||
| negative pion | pi- | 100000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| negative pion | pi- | 100000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| negative pion | pi- | 100000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| negative pion | pi- | 100000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| negative pion | pi- | 100000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 100000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 100000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| negative pion | pi- | 100000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 | ||
| negative pion | pi- | 100000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| negative pion | pi- | 100000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 100000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| negative pion | pi- | 100000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 988 | ||
| negative pion | pi- | 100000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 938 | ||
| negative pion | pi- | 100000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| negative pion | pi- | 100000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 950 | ||
| negative pion | pi- | 100000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 941 | ||
| negative pion | pi- | 100000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 879 | ||
| negative pion | pi- | 100000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1310 | ||
| negative pion | pi- | 100000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| negative pion | pi- | 100000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1460 | ||
| negative pion | pi- | 100000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| negative pion | pi- | 100000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 982 | ||
| negative pion | pi- | 100000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 986 | ||
| negative pion | pi- | 100000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| negative pion | pi- | 100000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1410 | ||
| negative pion | pi- | 100000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| negative pion | pi- | 100000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| negative pion | pi- | 100000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1430 | ||
| negative pion | pi- | 100000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1350 | ||
| negative pion | pi- | 100000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| negative pion | pi- | 100000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 100000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 100000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 100000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| negative pion | pi- | 100000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| negative pion | pi- | 100000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 100000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1460 | ||
| negative pion | pi- | 100000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 100000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| negative pion | pi- | 100000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 100000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1420 | ||
| negative pion | pi- | 100000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1430 | ||
| negative pion | pi- | 100000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| negative pion | pi- | 100000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| negative pion | pi- | 100000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 100000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 100000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| negative pion | pi- | 100000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 100000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 100000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 835 | ||
| negative pion | pi- | 100000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 100000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 835 | ||
| negative pion | pi- | 100000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 100000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1400 | ||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1440 | ||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1350 | ||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1520 | ||
| negative pion | pi- | 150000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 150000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| negative pion | pi- | 150000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 150000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 150000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| negative pion | pi- | 150000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1550 | ||
| negative pion | pi- | 150000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1460 | ||
| negative pion | pi- | 150000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1410 | ||
| negative pion | pi- | 150000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 150000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1560 | ||
| negative pion | pi- | 150000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1410 | ||
| negative pion | pi- | 150000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| negative pion | pi- | 150000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 150000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 150000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1660 | ||
| negative pion | pi- | 150000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| negative pion | pi- | 150000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1550 | ||
| negative pion | pi- | 150000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1420 | ||
| negative pion | pi- | 150000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1540 | ||
| negative pion | pi- | 150000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1300 | ||
| negative pion | pi- | 150000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| negative pion | pi- | 150000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 150000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1690 | ||
| negative pion | pi- | 150000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 | ||
| negative pion | pi- | 150000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| negative pion | pi- | 150000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 150000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 150000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| negative pion | pi- | 150000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| negative pion | pi- | 150000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 150000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 150000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 150000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 984 | ||
| negative pion | pi- | 150000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 150000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| negative pion | pi- | 150000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1390 | ||
| negative pion | pi- | 150000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1750 | ||
| negative pion | pi- | 150000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1550 | ||
| negative pion | pi- | 150000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| negative pion | pi- | 150000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| negative pion | pi- | 150000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1560 | ||
| negative pion | pi- | 150000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1600 | ||
| negative pion | pi- | 150000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 150000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1520 | ||
| negative pion | pi- | 150000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| negative pion | pi- | 150000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1680 | ||
| negative pion | pi- | 150000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| negative pion | pi- | 150000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 | ||
| negative pion | pi- | 150000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| negative pion | pi- | 150000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| negative pion | pi- | 150000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| negative pion | pi- | 150000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| negative pion | pi- | 150000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 150000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| negative pion | pi- | 150000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 150000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 150000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1660 | ||
| negative pion | pi- | 150000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| negative pion | pi- | 150000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1690 | ||
| negative pion | pi- | 150000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1620 | ||
| negative pion | pi- | 150000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1640 | ||
| negative pion | pi- | 150000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1520 | ||
| negative pion | pi- | 150000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1540 | ||
| negative pion | pi- | 150000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| negative pion | pi- | 150000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 150000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1400 | ||
| negative pion | pi- | 150000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 | ||
| negative pion | pi- | 150000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 150000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 907 | ||
| negative pion | pi- | 150000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 150000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 907 | ||
| negative pion | pi- | 150000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 150000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1520 | ||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1580 | ||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1460 | ||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1660 | ||
| negative pion | pi- | 200000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 200000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| negative pion | pi- | 200000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| negative pion | pi- | 200000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| negative pion | pi- | 200000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| negative pion | pi- | 200000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1730 | ||
| negative pion | pi- | 200000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1580 | ||
| negative pion | pi- | 200000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1530 | ||
| negative pion | pi- | 200000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| negative pion | pi- | 200000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1700 | ||
| negative pion | pi- | 200000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1560 | ||
| negative pion | pi- | 200000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| negative pion | pi- | 200000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 200000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1620 | ||
| negative pion | pi- | 200000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| negative pion | pi- | 200000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 | ||
| negative pion | pi- | 200000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1540 | ||
| negative pion | pi- | 200000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1670 | ||
| negative pion | pi- | 200000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1480 | ||
| negative pion | pi- | 200000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1520 | ||
| negative pion | pi- | 200000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| negative pion | pi- | 200000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1810 | ||
| negative pion | pi- | 200000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 200000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1600 | ||
| negative pion | pi- | 200000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 200000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1390 | ||
| negative pion | pi- | 200000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1310 | ||
| negative pion | pi- | 200000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 200000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| negative pion | pi- | 200000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| negative pion | pi- | 200000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| negative pion | pi- | 200000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| negative pion | pi- | 200000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| negative pion | pi- | 200000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1650 | ||
| negative pion | pi- | 200000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| negative pion | pi- | 200000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1910 | ||
| negative pion | pi- | 200000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1650 | ||
| negative pion | pi- | 200000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1170 | ||
| negative pion | pi- | 200000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| negative pion | pi- | 200000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1800 | ||
| negative pion | pi- | 200000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 200000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1620 | ||
| negative pion | pi- | 200000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 200000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1670 | ||
| negative pion | pi- | 200000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1520 | ||
| negative pion | pi- | 200000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| negative pion | pi- | 200000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1870 | ||
| negative pion | pi- | 200000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1580 | ||
| negative pion | pi- | 200000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1630 | ||
| negative pion | pi- | 200000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| negative pion | pi- | 200000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1460 | ||
| negative pion | pi- | 200000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| negative pion | pi- | 200000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| negative pion | pi- | 200000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 200000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 200000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| negative pion | pi- | 200000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| negative pion | pi- | 200000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| negative pion | pi- | 200000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1780 | ||
| negative pion | pi- | 200000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| negative pion | pi- | 200000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1900 | ||
| negative pion | pi- | 200000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1690 | ||
| negative pion | pi- | 200000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1780 | ||
| negative pion | pi- | 200000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1630 | ||
| negative pion | pi- | 200000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 | ||
| negative pion | pi- | 200000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 200000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1480 | ||
| negative pion | pi- | 200000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| negative pion | pi- | 200000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| negative pion | pi- | 200000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 200000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1420 | ||
| negative pion | pi- | 200000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| negative pion | pi- | 200000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| negative pion | pi- | 200000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 969 | ||
| negative pion | pi- | 200000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| negative pion | pi- | 200000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 969 | ||
| negative pion | pi- | 200000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| negative pion | pi- | 200000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 |